{
  "totalGenes": 19,
  "pharmcatVersion": "v1.4.0-13-gebf5ac2\n",
  "generatedOn": "February 18, 2022",
  "geneCalls": [
    {
      "diplotypes": [
        "rs2231142 reference (G)/rs2231142 reference (G)"
      ],
      "gene": "ABCG2",
      "hasUncalledHaps": false,
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "messages": [],
      "totalMissingVariants": 0,
      "totalVariants": 1,
      "variants": [
        {
          "gene": "ABCG2",
          "chromosome": "chr4",
          "position": 88131171,
          "dbSnpId": "rs2231142",
          "call": "G|G",
          "alleles": [
            "rs2231142 variant (T)"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "unphased": false,
      "extra-position-notes": []
    },
    {
      "diplotypes": [
        "Reference/Reference"
      ],
      "gene": "CACNA1S",
      "hasUncalledHaps": false,
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "messages": [],
      "totalMissingVariants": 0,
      "totalVariants": 2,
      "variants": [
        {
          "gene": "CACNA1S",
          "chromosome": "chr1",
          "position": 201060815,
          "dbSnpId": "rs1800559",
          "call": "C|C",
          "alleles": [
            "c.3257G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CACNA1S",
          "chromosome": "chr1",
          "position": 201091993,
          "dbSnpId": "rs772226819",
          "call": "G|G",
          "alleles": [
            "c.520C>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "unphased": false,
      "extra-position-notes": []
    },
    {
      "diplotypes": [
        "No CPIC variants found"
      ],
      "gene": "CFTR",
      "hasUncalledHaps": false,
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "messages": [],
      "totalMissingVariants": 0,
      "totalVariants": 39,
      "variants": [
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117509035,
          "dbSnpId": "rs397508256",
          "call": "G|G",
          "alleles": [
            "E56K"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117509069,
          "dbSnpId": "rs368505753",
          "call": "C|C",
          "alleles": [
            "P67L"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117509089,
          "dbSnpId": "rs115545701",
          "call": "C|C",
          "alleles": [
            "R74W"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117530953,
          "dbSnpId": "rs113993958",
          "call": "G|G",
          "alleles": [
            "D110H"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117530955,
          "dbSnpId": "rs397508537",
          "call": "C|C",
          "alleles": [
            "D110E"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117530974,
          "dbSnpId": "rs77834169",
          "call": "C|C",
          "alleles": [
            "R117C"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117530975,
          "dbSnpId": "rs78655421",
          "call": "G|G",
          "alleles": [
            "R117H"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117534318,
          "dbSnpId": "rs80282562",
          "call": "G|G",
          "alleles": [
            "G178R"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117534363,
          "dbSnpId": "rs397508759",
          "call": "G|G",
          "alleles": [
            "E193K"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117534368,
          "dbSnpId": "rs397508761",
          "call": "A|A",
          "alleles": [
            "711+3A->G"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117535285,
          "dbSnpId": "rs121908752",
          "call": "T|T",
          "alleles": [
            "L206W"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117540270,
          "dbSnpId": "rs77932196",
          "call": "G|G",
          "alleles": [
            "R347H"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117540285,
          "dbSnpId": "rs121908753",
          "call": "G|G",
          "alleles": [
            "R352Q"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117548795,
          "dbSnpId": "rs74551128",
          "call": "C|C",
          "alleles": [
            "A455E"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117587799,
          "dbSnpId": "rs121908757",
          "call": "A|A",
          "alleles": [
            "S549R(A>C)"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117587800,
          "dbSnpId": "rs121908755",
          "call": "G|G",
          "alleles": [
            "S549N"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117587801,
          "dbSnpId": "rs121909005",
          "call": "T|T",
          "alleles": [
            "S549R(T>G)"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117587805,
          "dbSnpId": "rs121909013",
          "call": "G|G",
          "alleles": [
            "G551S"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117587806,
          "dbSnpId": "rs75527207",
          "call": "G|G",
          "alleles": [
            "G551D"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117590409,
          "dbSnpId": "rs397508288",
          "call": "A|A",
          "alleles": [
            "D579G"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117594930,
          "dbSnpId": "rs397508387",
          "call": "G|G",
          "alleles": [
            "E831X"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117602868,
          "dbSnpId": "rs80224560",
          "call": "G|G",
          "alleles": [
            "2789+5G->A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117603708,
          "dbSnpId": "rs397508442",
          "call": "C|C",
          "alleles": [
            "S945L"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117606695,
          "dbSnpId": "rs141033578",
          "call": "C|C",
          "alleles": [
            "S977F"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611555,
          "dbSnpId": "rs76151804",
          "call": "A|A",
          "alleles": [
            "3272-26A->G"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611595,
          "dbSnpId": "rs150212784",
          "call": "T|T",
          "alleles": [
            "F1052V"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611620,
          "dbSnpId": "rs397508513",
          "call": "A|A",
          "alleles": [
            "K1060T"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611640,
          "dbSnpId": "rs121909020",
          "call": "G|G",
          "alleles": [
            "A1067T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611646,
          "dbSnpId": "rs200321110",
          "call": "G|G",
          "alleles": [
            "G1069R"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611649,
          "dbSnpId": "rs202179988",
          "call": "C|C",
          "alleles": [
            "R1070W"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611650,
          "dbSnpId": "rs78769542",
          "call": "G|G",
          "alleles": [
            "R1070Q"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611663,
          "dbSnpId": "rs186045772",
          "call": "T|T",
          "alleles": [
            "F1074L"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117614699,
          "dbSnpId": "rs75541969",
          "call": "G|G",
          "alleles": [
            "D1152H"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117639961,
          "dbSnpId": "rs75039782",
          "call": "C|C",
          "alleles": [
            "3849+10kbC->T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117642451,
          "dbSnpId": "rs267606723",
          "call": "G|G",
          "alleles": [
            "G1244E"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117642472,
          "dbSnpId": "rs74503330",
          "call": "G|G",
          "alleles": [
            "S1251N"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117642483,
          "dbSnpId": "rs121909041",
          "call": "T|T",
          "alleles": [
            "S1255P"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117642528,
          "dbSnpId": "rs11971167",
          "call": "G|G",
          "alleles": [
            "D1270N"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117664770,
          "dbSnpId": "rs193922525",
          "call": "G|G",
          "alleles": [
            "G1349D"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "unphased": false,
      "extra-position-notes": []
    },
    {
      "diplotypes": [
        "*1/*1"
      ],
      "gene": "CYP2B6",
      "hasUncalledHaps": false,
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "messages": [],
      "totalMissingVariants": 0,
      "totalVariants": 35,
      "variants": [
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991224,
          "dbSnpId": "rs34223104",
          "call": "T|T",
          "alleles": [
            "*22",
            "*34",
            "*35",
            "*36"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991367,
          "dbSnpId": "rs34883432",
          "call": "A|A",
          "alleles": [
            "*10"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991369,
          "dbSnpId": "rs8192709",
          "call": "C|C",
          "alleles": [
            "*2",
            "*10"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991381,
          "dbSnpId": "rs33973337",
          "call": "A|A",
          "alleles": [
            "*17"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991388,
          "dbSnpId": "rs33980385",
          "call": "A|A",
          "alleles": [
            "*17"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991390,
          "dbSnpId": "rs33926104",
          "call": "C|C",
          "alleles": [
            "*17"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991391,
          "dbSnpId": "rs34284776",
          "call": "G|G",
          "alleles": [
            "*17"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991441,
          "dbSnpId": "rs35303484",
          "call": "A|A",
          "alleles": [
            "*11"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004015,
          "dbSnpId": "rs281864907",
          "call": "T|T",
          "alleles": [
            "*38"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004125,
          "dbSnpId": "rs36060847",
          "call": "G|G",
          "alleles": [
            "*12"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004158,
          "dbSnpId": "rs186335453",
          "call": "G|G",
          "alleles": [
            "*35"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004303,
          "dbSnpId": "rs139801276",
          "call": "T|T",
          "alleles": [
            "*35"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004377,
          "dbSnpId": "rs12721655",
          "call": "A|A",
          "alleles": [
            "*8",
            "*13"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004381,
          "dbSnpId": "rs35773040",
          "call": "G|G",
          "alleles": [
            "*14"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004406,
          "dbSnpId": "rs145884402",
          "call": "G|G",
          "alleles": [
            "*35"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41006919,
          "dbSnpId": "rs3826711",
          "call": "C|C",
          "alleles": [
            "*26"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41006923,
          "dbSnpId": "rs36056539",
          "call": "C|C",
          "alleles": [
            "*20"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41006936,
          "dbSnpId": "rs3745274",
          "call": "G|G",
          "alleles": [
            "*6",
            "*7",
            "*9",
            "*13",
            "*19",
            "*20",
            "*26",
            "*34",
            "*36",
            "*37",
            "*38"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41006968,
          "dbSnpId": "rs373489637",
          "call": "T|T",
          "alleles": [
            "*37"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41007013,
          "dbSnpId": "rs36079186",
          "call": "T|T",
          "alleles": [
            "*27",
            "*35"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41009350,
          "dbSnpId": "rs45482602",
          "call": "C|C",
          "alleles": [
            "*3"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41009358,
          "dbSnpId": "rs2279343",
          "call": "A|A",
          "alleles": [
            "*4",
            "*6",
            "*7",
            "*13",
            "*18",
            "*19",
            "*20",
            "*26",
            "*34",
            "*36",
            "*37",
            "*38"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41010006,
          "dbSnpId": "rs139029625",
          "call": "G|G",
          "alleles": [
            "*35"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41010088,
          "dbSnpId": "rs34698757",
          "call": "C|C",
          "alleles": [
            "*28"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41010108,
          "dbSnpId": "rs193922917",
          "call": "C|C",
          "alleles": [
            "*31"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41012316,
          "dbSnpId": "rs28399499",
          "call": "T|T",
          "alleles": [
            "*18"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41012339,
          "dbSnpId": "rs34826503",
          "call": "C|C",
          "alleles": [
            "*19"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41012465,
          "dbSnpId": "rs34097093",
          "call": "C|C",
          "alleles": [
            "*28"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41012693,
          "dbSnpId": "rs35979566",
          "call": "T|T",
          "alleles": [
            "*15"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41012740,
          "dbSnpId": "rs193922918",
          "call": "G|G",
          "alleles": [
            "*32"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41012803,
          "dbSnpId": "rs35010098",
          "call": "C|C",
          "alleles": [
            "*21"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41016726,
          "dbSnpId": "rs3211369",
          "call": "A|A",
          "alleles": [
            "*23"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41016778,
          "dbSnpId": "rs564083989",
          "call": "G|G",
          "alleles": [
            "*24"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41016805,
          "dbSnpId": null,
          "call": "A|A",
          "alleles": [
            "*25"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41016810,
          "dbSnpId": "rs3211371",
          "call": "C|C",
          "alleles": [
            "*5",
            "*7",
            "*33",
            "*34"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "unphased": false,
      "extra-position-notes": []
    },
    {
      "diplotypes": [
        "*38/*38"
      ],
      "gene": "CYP2C19",
      "hasUncalledHaps": false,
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "messages": [],
      "totalMissingVariants": 0,
      "totalVariants": 34,
      "variants": [
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94761900,
          "dbSnpId": "rs12248560",
          "call": "C|C",
          "alleles": [
            "*4",
            "*17"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762706,
          "dbSnpId": "rs28399504",
          "call": "A|A",
          "alleles": [
            "*4"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762712,
          "dbSnpId": "rs367543002",
          "call": "C|C",
          "alleles": [
            "*34"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762715,
          "dbSnpId": "rs367543003",
          "call": "T|T",
          "alleles": [
            "*34"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762755,
          "dbSnpId": "rs55752064",
          "call": "T|T",
          "alleles": [
            "*14"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762760,
          "dbSnpId": "rs17882687",
          "call": "A|A",
          "alleles": [
            "*15",
            "*28",
            "*35",
            "*39"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762788,
          "dbSnpId": "rs1564656981",
          "call": "A|A",
          "alleles": [
            "*29"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762856,
          "dbSnpId": "rs1564657013",
          "call": "A|A",
          "alleles": [
            "*19"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775106,
          "dbSnpId": "rs145328984",
          "call": "C|C",
          "alleles": [
            "*30"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775121,
          "dbSnpId": "rs1564660997",
          "call": "C|C",
          "alleles": [
            "*31"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775160,
          "dbSnpId": "rs118203756",
          "call": "G|G",
          "alleles": [
            "*23"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775185,
          "dbSnpId": "rs1288601658",
          "call": "A|A",
          "alleles": [
            "*32"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775367,
          "dbSnpId": "rs12769205",
          "call": "A|A",
          "alleles": [
            "*2",
            "*35"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775416,
          "dbSnpId": "rs41291556",
          "call": "T|T",
          "alleles": [
            "*8"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775423,
          "dbSnpId": "rs17885179",
          "call": "A|A",
          "alleles": [
            "*39"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775453,
          "dbSnpId": "rs72552267",
          "call": "G|G",
          "alleles": [
            "*6"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775489,
          "dbSnpId": "rs17884712",
          "call": "G|G",
          "alleles": [
            "*9"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775507,
          "dbSnpId": "rs58973490",
          "call": "G|G",
          "alleles": [
            "*2",
            "*11"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94780574,
          "dbSnpId": "rs140278421",
          "call": "G|G",
          "alleles": [
            "*22"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94780579,
          "dbSnpId": "rs370803989",
          "call": "G|G",
          "alleles": [
            "*33"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94780653,
          "dbSnpId": "rs4986893",
          "call": "G|G",
          "alleles": [
            "*3"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94781858,
          "dbSnpId": "rs6413438",
          "call": "C|C",
          "alleles": [
            "*10"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94781859,
          "dbSnpId": "rs4244285",
          "call": "G|G",
          "alleles": [
            "*2"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94781944,
          "dbSnpId": "rs375781227",
          "call": "G|G",
          "alleles": [
            "*26"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94781999,
          "dbSnpId": "rs72558186",
          "call": "T|T",
          "alleles": [
            "*7"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94842861,
          "dbSnpId": "rs138142612",
          "call": "G|G",
          "alleles": [
            "*18"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94842866,
          "dbSnpId": "rs3758581",
          "call": "A|A",
          "alleles": [
            "*2",
            "*3",
            "*4",
            "*5",
            "*6",
            "*8",
            "*9",
            "*10",
            "*11",
            "*12",
            "*13",
            "*14",
            "*15",
            "*17",
            "*18",
            "*19",
            "*22",
            "*23",
            "*24",
            "*25",
            "*26",
            "*28",
            "*29",
            "*31",
            "*32",
            "*33",
            "*35",
            "*39"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94842879,
          "dbSnpId": "rs118203757",
          "call": "G|G",
          "alleles": [
            "*24"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94842995,
          "dbSnpId": "rs113934938",
          "call": "G|G",
          "alleles": [
            "*28"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94849995,
          "dbSnpId": "rs17879685",
          "call": "C|C",
          "alleles": [
            "*13"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94852738,
          "dbSnpId": "rs56337013",
          "call": "C|C",
          "alleles": [
            "*5"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94852765,
          "dbSnpId": "rs192154563",
          "call": "C|C",
          "alleles": [
            "*16"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94852785,
          "dbSnpId": "rs118203759",
          "call": "C|C",
          "alleles": [
            "*25"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94852914,
          "dbSnpId": "rs55640102",
          "call": "A|A",
          "alleles": [
            "*12"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "unphased": false,
      "extra-position-notes": []
    },
    {
      "diplotypes": [
        "*1/*1"
      ],
      "gene": "CYP2C9",
      "hasUncalledHaps": false,
      "outsideCall": false,
      "variantsOfInterest": [
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94645745,
          "dbSnpId": "rs12777823",
          "call": "G|G",
          "alleles": [],
          "phased": true,
          "wildtypeAllele": null,
          "mismatch": false,
          "warnings": []
        }
      ],
      "messages": [],
      "totalMissingVariants": 0,
      "totalVariants": 70,
      "variants": [
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94938683,
          "dbSnpId": "rs114071557",
          "call": "A|A",
          "alleles": [
            "*36"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94938737,
          "dbSnpId": "rs67807361",
          "call": "C|C",
          "alleles": [
            "*7"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94938771,
          "dbSnpId": "rs142240658",
          "call": "C|C",
          "alleles": [
            "*21"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94938803,
          "dbSnpId": "rs2031308986",
          "call": "A|A",
          "alleles": [
            "*22"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94938828,
          "dbSnpId": "rs564813580",
          "call": "A|A",
          "alleles": [
            "*37"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94941897,
          "dbSnpId": "rs371055887",
          "call": "G|G",
          "alleles": [
            "*20"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94941915,
          "dbSnpId": null,
          "call": "G|G",
          "alleles": [
            "*23"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94941958,
          "dbSnpId": "rs72558187",
          "call": "T|T",
          "alleles": [
            "*13"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94941976,
          "dbSnpId": null,
          "call": "G|G",
          "alleles": [
            "*38"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94941982,
          "dbSnpId": "rs762239445",
          "call": "G|G",
          "alleles": [
            "*39"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942018,
          "dbSnpId": null,
          "call": "T|T",
          "alleles": [
            "*40"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942205,
          "dbSnpId": "rs1304490498",
          "call": "CAATGGAAAGA|CAATGGAAAGA",
          "alleles": [
            "*25"
          ],
          "phased": true,
          "wildtypeAllele": "CAATGGAAAGA",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942216,
          "dbSnpId": "rs774607211",
          "call": "A|A",
          "alleles": [
            "*41"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942230,
          "dbSnpId": "rs767576260",
          "call": "C|C",
          "alleles": [
            "*43"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942231,
          "dbSnpId": "rs12414460",
          "call": "G|G",
          "alleles": [
            "*42"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942233,
          "dbSnpId": "rs375805362",
          "call": "C|C",
          "alleles": [
            "*62"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942234,
          "dbSnpId": "rs72558189",
          "call": "G|G",
          "alleles": [
            "*14",
            "*35"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942249,
          "dbSnpId": "rs200965026",
          "call": "C|C",
          "alleles": [
            "*26",
            "*44"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942254,
          "dbSnpId": "rs199523631",
          "call": "C|C",
          "alleles": [
            "*45"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942255,
          "dbSnpId": "rs200183364",
          "call": "G|G",
          "alleles": [
            "*33"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942290,
          "dbSnpId": "rs1799853",
          "call": "C|C",
          "alleles": [
            "*2",
            "*35",
            "*61"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942291,
          "dbSnpId": "rs141489852",
          "call": "G|G",
          "alleles": [
            "*63"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942305,
          "dbSnpId": "rs754487195",
          "call": "G|G",
          "alleles": [
            "*46"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942306,
          "dbSnpId": "rs1289704600",
          "call": "C|C",
          "alleles": [
            "*72"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942308,
          "dbSnpId": "rs17847037",
          "call": "C|C",
          "alleles": [
            "*73"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942309,
          "dbSnpId": "rs7900194",
          "call": "G|G",
          "alleles": [
            "*8",
            "*27"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947439,
          "dbSnpId": null,
          "call": "G|G",
          "alleles": [
            "*74"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947782,
          "dbSnpId": "rs72558190",
          "call": "C|C",
          "alleles": [
            "*15"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947785,
          "dbSnpId": "rs774550549",
          "call": "C|C",
          "alleles": [
            "*47"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947869,
          "dbSnpId": null,
          "call": "A|A",
          "alleles": [
            "*69"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947907,
          "dbSnpId": null,
          "call": "A|A",
          "alleles": [
            "*57"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947917,
          "dbSnpId": "rs1326630788",
          "call": "T|T",
          "alleles": [
            "*48"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947938,
          "dbSnpId": "rs2031531005",
          "call": "A|A",
          "alleles": [
            "*28"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94949129,
          "dbSnpId": null,
          "call": "A|A",
          "alleles": [
            "*49"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94949144,
          "dbSnpId": null,
          "call": "C|C",
          "alleles": [
            "*50"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94949217,
          "dbSnpId": "rs2256871",
          "call": "A|A",
          "alleles": [
            "*9"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94949280,
          "dbSnpId": "rs9332130",
          "call": "A|A",
          "alleles": [
            "*10",
            "*71"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94949281,
          "dbSnpId": "rs9332131",
          "call": "GA|GA",
          "alleles": [
            "*6"
          ],
          "phased": true,
          "wildtypeAllele": "GA",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94972119,
          "dbSnpId": "rs182132442",
          "call": "C|C",
          "alleles": [
            "*29"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94972123,
          "dbSnpId": null,
          "call": "C|C",
          "alleles": [
            "*64"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94972134,
          "dbSnpId": null,
          "call": "A|A",
          "alleles": [
            "*51"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94972179,
          "dbSnpId": "rs72558192",
          "call": "A|A",
          "alleles": [
            "*16"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94972180,
          "dbSnpId": "rs988617574",
          "call": "C|C",
          "alleles": [
            "*52"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94972233,
          "dbSnpId": "rs1237225311",
          "call": "C|C",
          "alleles": [
            "*53"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981199,
          "dbSnpId": null,
          "call": "G|G",
          "alleles": [
            "*65"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981201,
          "dbSnpId": "rs57505750",
          "call": "T|T",
          "alleles": [
            "*31"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981224,
          "dbSnpId": "rs28371685",
          "call": "C|C",
          "alleles": [
            "*11"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981225,
          "dbSnpId": "rs367826293",
          "call": "G|G",
          "alleles": [
            "*34"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981230,
          "dbSnpId": "rs1274535931",
          "call": "C|C",
          "alleles": [
            "*58"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981250,
          "dbSnpId": "rs750820937",
          "call": "C|C",
          "alleles": [
            "*54"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981281,
          "dbSnpId": "rs749060448",
          "call": "G|G",
          "alleles": [
            "*24"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981296,
          "dbSnpId": "rs1057910",
          "call": "A|A",
          "alleles": [
            "*3",
            "*18",
            "*68"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981297,
          "dbSnpId": "rs56165452",
          "call": "T|T",
          "alleles": [
            "*4"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981301,
          "dbSnpId": "rs28371686",
          "call": "C|C",
          "alleles": [
            "*5"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981302,
          "dbSnpId": "rs1250577724",
          "call": "C|C",
          "alleles": [
            "*55"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981305,
          "dbSnpId": "rs578144976",
          "call": "C|C",
          "alleles": [
            "*66"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981365,
          "dbSnpId": null,
          "call": "C|C",
          "alleles": [
            "*17"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981371,
          "dbSnpId": "rs542577750",
          "call": "G|G",
          "alleles": [
            "*68"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94986042,
          "dbSnpId": "rs764211126",
          "call": "A|A",
          "alleles": [
            "*56"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94986073,
          "dbSnpId": "rs72558193",
          "call": "A|A",
          "alleles": [
            "*18"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94986136,
          "dbSnpId": "rs1254213342",
          "call": "A|A",
          "alleles": [
            "*75"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988852,
          "dbSnpId": "rs776908257",
          "call": "C|C",
          "alleles": [
            "*67"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988855,
          "dbSnpId": null,
          "call": "A|A",
          "alleles": [
            "*59"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988880,
          "dbSnpId": null,
          "call": "G|G",
          "alleles": [
            "*70"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988917,
          "dbSnpId": "rs769942899",
          "call": "G|G",
          "alleles": [
            "*19"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988925,
          "dbSnpId": "rs202201137",
          "call": "A|A",
          "alleles": [
            "*61"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988955,
          "dbSnpId": "rs767284820",
          "call": "T|T",
          "alleles": [
            "*60"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988984,
          "dbSnpId": "rs781583846",
          "call": "G|G",
          "alleles": [
            "*30"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94989020,
          "dbSnpId": "rs9332239",
          "call": "C|C",
          "alleles": [
            "*12",
            "*71"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94989023,
          "dbSnpId": "rs868182778",
          "call": "G|G",
          "alleles": [
            "*32"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "unphased": false,
      "extra-position-notes": []
    },
    {
      "diplotypes": [
        "*1/*3"
      ],
      "gene": "CYP2D6",
      "variantsOfInterestUnspecified": true,
      "outsideCall": true,
      "warnings": [
        "CYP2D6 genotypes are called by a separate algorithm from other genes in the PharmCAT report.  Please refer to <a href=\"https://github.com/PharmGKB/PharmCAT/wiki/Determining-Alleles\">the PharmCAT wiki</a> for more information."
      ],
      "variantsUnspecified": true,
      "totalMissingVariants": 0,
      "totalVariants": 0,
      "phaseStatus": "Unavailable for calls made outside PharmCAT",
      "extra-position-notes": [],
      "hasUncalledHaps": false,
      "messages": [
        "CYP2D6 genotypes are called by a separate algorithm from other genes in the PharmCAT report.  Please refer to <a href=\"https://github.com/PharmGKB/PharmCAT/wiki/Determining-Alleles\">the PharmCAT wiki</a> for more information."
      ],
      "unphased": false
    },
    {
      "diplotypes": [
        "*1/*1"
      ],
      "gene": "CYP3A5",
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "warnings": [
        "The CYP3A5 gene is on the negative chromosomal strand, all genotype calls for CYP3A5 in this report refer to the positive chromosomal strand.  Therefore, genotype calls are complemented from gene bases."
      ],
      "totalMissingVariants": 0,
      "totalVariants": 5,
      "variants": [
        {
          "gene": "CYP3A5",
          "chromosome": "chr7",
          "position": 99652770,
          "dbSnpId": "rs41303343",
          "call": "T|T",
          "alleles": [
            "*7"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A5",
          "chromosome": "chr7",
          "position": 99660516,
          "dbSnpId": "rs28383479",
          "call": "C|C",
          "alleles": [
            "*9"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A5",
          "chromosome": "chr7",
          "position": 99665212,
          "dbSnpId": "rs10264272",
          "call": "C|C",
          "alleles": [
            "*6"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A5",
          "chromosome": "chr7",
          "position": 99672916,
          "dbSnpId": "rs776746",
          "call": "T|T",
          "alleles": [
            "*3"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A5",
          "chromosome": "chr7",
          "position": 99676198,
          "dbSnpId": "rs55817950",
          "call": "G|G",
          "alleles": [
            "*8"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "extra-position-notes": [],
      "hasUncalledHaps": false,
      "messages": [],
      "unphased": false
    },
    {
      "diplotypes": [
        "*1/*1"
      ],
      "gene": "CYP4F2",
      "hasUncalledHaps": false,
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "messages": [],
      "totalMissingVariants": 0,
      "totalVariants": 2,
      "variants": [
        {
          "gene": "CYP4F2",
          "chromosome": "chr19",
          "position": 15879621,
          "dbSnpId": "rs2108622",
          "call": "C|C",
          "alleles": [
            "*3"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP4F2",
          "chromosome": "chr19",
          "position": 15897578,
          "dbSnpId": "rs3093105",
          "call": "A|A",
          "alleles": [
            "*2"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "unphased": false,
      "extra-position-notes": []
    },
    {
      "diplotypes": [
        "Reference/Reference"
      ],
      "gene": "DPYD",
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "warnings": [
        "The DPYD gene is on the negative chromosomal strand, all genotype calls for DPYD in this report refer to the positive chromosomal strand.  Therefore, genotype calls are complemented from gene bases."
      ],
      "totalMissingVariants": 0,
      "totalVariants": 83,
      "variants": [
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97078987,
          "dbSnpId": "rs114096998",
          "call": "G|G",
          "alleles": [
            "c.3067C>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97078993,
          "dbSnpId": "rs148799944",
          "call": "C|C",
          "alleles": [
            "c.3061G>C"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079005,
          "dbSnpId": "rs140114515",
          "call": "C|C",
          "alleles": [
            "c.3049G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079071,
          "dbSnpId": "rs1801268",
          "call": "C|C",
          "alleles": [
            "c.2983G>T (*10)"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079076,
          "dbSnpId": "rs139459586",
          "call": "A|A",
          "alleles": [
            "c.2978T>G"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079077,
          "dbSnpId": "rs202144771",
          "call": "G|G",
          "alleles": [
            "c.2977C>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079121,
          "dbSnpId": "rs72547601",
          "call": "T|T",
          "alleles": [
            "c.2933A>G"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079133,
          "dbSnpId": "rs72547602",
          "call": "T|T",
          "alleles": [
            "c.2921A>T"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079139,
          "dbSnpId": "rs145529148",
          "call": "T|T",
          "alleles": [
            "c.2915A>G"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97082365,
          "dbSnpId": "rs141044036",
          "call": "T|T",
          "alleles": [
            "c.2872A>G"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97082391,
          "dbSnpId": "rs67376798",
          "call": "T|T",
          "alleles": [
            "c.2846A>T"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97098598,
          "dbSnpId": "rs1801267",
          "call": "C|C",
          "alleles": [
            "c.2657G>A (*9B)"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97098599,
          "dbSnpId": "rs147545709",
          "call": "G|G",
          "alleles": [
            "c.2656C>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97098616,
          "dbSnpId": "rs55674432",
          "call": "C|C",
          "alleles": [
            "c.2639G>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97098632,
          "dbSnpId": "rs201035051",
          "call": "T|T",
          "alleles": [
            "c.2623A>C"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97193109,
          "dbSnpId": "rs60139309",
          "call": "T|T",
          "alleles": [
            "c.2582A>G"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97193209,
          "dbSnpId": "rs200687447",
          "call": "C|C",
          "alleles": [
            "c.2482G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97234958,
          "dbSnpId": "rs199634007",
          "call": "G|G",
          "alleles": [
            "c.2336C>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97234991,
          "dbSnpId": "rs56005131",
          "call": "G|G",
          "alleles": [
            "c.2303C>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97305279,
          "dbSnpId": "rs112766203",
          "call": "G|G",
          "alleles": [
            "c.2279C>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97305363,
          "dbSnpId": "rs60511679",
          "call": "A|A",
          "alleles": [
            "c.2195T>G"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97305364,
          "dbSnpId": "rs1801160",
          "call": "C|C",
          "alleles": [
            "c.2194G>A (*6)"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97305372,
          "dbSnpId": "rs146529561",
          "call": "G|G",
          "alleles": [
            "c.2186C>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97306195,
          "dbSnpId": "rs145548112",
          "call": "C|C",
          "alleles": [
            "c.2161G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97373598,
          "dbSnpId": "rs137999090",
          "call": "C|C",
          "alleles": [
            "c.2021G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97373629,
          "dbSnpId": "rs138545885",
          "call": "C|C",
          "alleles": [
            "c.1990G>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97382461,
          "dbSnpId": "rs55971861",
          "call": "T|T",
          "alleles": [
            "c.1906A>C"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450058,
          "dbSnpId": "rs3918290",
          "call": "C|C",
          "alleles": [
            "c.1905+1G>A (*2A)"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450059,
          "dbSnpId": "rs3918289",
          "call": "G|G",
          "alleles": [
            "c.1905C>G"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450065,
          "dbSnpId": "rs72549303",
          "call": "TG|TG",
          "alleles": [
            "c.1898delC (*3)"
          ],
          "phased": true,
          "wildtypeAllele": "TG",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450068,
          "dbSnpId": "rs17376848",
          "call": "A|A",
          "alleles": [
            "c.1896T>C"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450168,
          "dbSnpId": "rs147601618",
          "call": "A|A",
          "alleles": [
            "c.1796T>C"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450187,
          "dbSnpId": "rs145773863",
          "call": "C|C",
          "alleles": [
            "c.1777G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450189,
          "dbSnpId": "rs138616379",
          "call": "C|C",
          "alleles": [
            "c.1775G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450190,
          "dbSnpId": "rs59086055",
          "call": "G|G",
          "alleles": [
            "c.1774C>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515784,
          "dbSnpId": "rs201615754",
          "call": "C|C",
          "alleles": [
            "c.1682G>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515787,
          "dbSnpId": "rs55886062",
          "call": "A|A",
          "alleles": [
            "c.1679T>G (*13)"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515839,
          "dbSnpId": "rs1801159",
          "call": "T|T",
          "alleles": [
            "c.1627A>G (*5)"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515851,
          "dbSnpId": "rs142619737",
          "call": "C|C",
          "alleles": [
            "c.1615G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515865,
          "dbSnpId": "rs1801158",
          "call": "C|C",
          "alleles": [
            "c.1601G>A (*4)"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515889,
          "dbSnpId": "rs190951787",
          "call": "G|G",
          "alleles": [
            "c.1577C>G"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515923,
          "dbSnpId": "rs148994843",
          "call": "C|C",
          "alleles": [
            "c.1543G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549565,
          "dbSnpId": "rs138391898",
          "call": "C|C",
          "alleles": [
            "c.1519G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549600,
          "dbSnpId": "rs111858276",
          "call": "T|T",
          "alleles": [
            "c.1484A>G"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549609,
          "dbSnpId": "rs72549304",
          "call": "G|G",
          "alleles": [
            "c.1475C>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549681,
          "dbSnpId": "rs199549923",
          "call": "G|G",
          "alleles": [
            "c.1403C>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549713,
          "dbSnpId": "rs57918000",
          "call": "G|G",
          "alleles": [
            "c.1371C>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549726,
          "dbSnpId": "rs144395748",
          "call": "G|G",
          "alleles": [
            "c.1358C>G"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549735,
          "dbSnpId": "rs72975710",
          "call": "G|G",
          "alleles": [
            "c.1349C>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573785,
          "dbSnpId": "rs186169810",
          "call": "A|A",
          "alleles": [
            "c.1314T>G"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573805,
          "dbSnpId": "rs142512579",
          "call": "C|C",
          "alleles": [
            "c.1294G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573821,
          "dbSnpId": "rs764666241",
          "call": "C|C",
          "alleles": [
            "c.1278G>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573839,
          "dbSnpId": "rs200064537",
          "call": "A|A",
          "alleles": [
            "c.1260T>A"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573863,
          "dbSnpId": "rs56038477",
          "call": "C|C",
          "alleles": [
            "c.1129-5923C>G, c.1236G>A (HapB3)"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573881,
          "dbSnpId": "rs61622928",
          "call": "C|C",
          "alleles": [
            "c.1218G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573918,
          "dbSnpId": "rs143815742",
          "call": "C|C",
          "alleles": [
            "c.1181G>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573919,
          "dbSnpId": "rs140602333",
          "call": "G|G",
          "alleles": [
            "c.1180C>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573943,
          "dbSnpId": "rs78060119",
          "call": "C|C",
          "alleles": [
            "c.1156G>T (*12)"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97579893,
          "dbSnpId": "rs75017182",
          "call": "G|G",
          "alleles": [
            "c.1129-5923C>G, c.1236G>A (HapB3)"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97593238,
          "dbSnpId": "rs72549305",
          "call": "T|T",
          "alleles": [
            "c.1108A>G"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97593289,
          "dbSnpId": "rs143154602",
          "call": "G|G",
          "alleles": [
            "c.1057C>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97593322,
          "dbSnpId": "rs183385770",
          "call": "C|C",
          "alleles": [
            "c.1024G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97593343,
          "dbSnpId": "rs72549306",
          "call": "C|C",
          "alleles": [
            "c.1003G>T (*11)"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97593379,
          "dbSnpId": "rs201018345",
          "call": "C|C",
          "alleles": [
            "c.967G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97595083,
          "dbSnpId": "rs145112791",
          "call": "G|G",
          "alleles": [
            "c.934C>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97595088,
          "dbSnpId": "rs150437414",
          "call": "A|A",
          "alleles": [
            "c.929T>C"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97595149,
          "dbSnpId": "rs146356975",
          "call": "T|T",
          "alleles": [
            "c.868A>G"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97679170,
          "dbSnpId": "rs45589337",
          "call": "T|T",
          "alleles": [
            "c.775A>G"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97691776,
          "dbSnpId": "rs1801266",
          "call": "G|G",
          "alleles": [
            "c.703C>T (*8)"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97699399,
          "dbSnpId": "rs72549307",
          "call": "T|T",
          "alleles": [
            "c.632A>G"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97699430,
          "dbSnpId": "rs72549308",
          "call": "T|T",
          "alleles": [
            "c.601A>C"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97699474,
          "dbSnpId": "rs115232898",
          "call": "T|T",
          "alleles": [
            "c.557A>G"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97699506,
          "dbSnpId": "rs6670886",
          "call": "C|C",
          "alleles": [
            "c.525G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97699533,
          "dbSnpId": "rs139834141",
          "call": "C|C",
          "alleles": [
            "c.498G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97699535,
          "dbSnpId": "rs2297595",
          "call": "T|T",
          "alleles": [
            "c.496A>G"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97721542,
          "dbSnpId": "rs200562975",
          "call": "T|T",
          "alleles": [
            "c.451A>G"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97721650,
          "dbSnpId": "rs141462178",
          "call": "T|T",
          "alleles": [
            "c.343A>G"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97740400,
          "dbSnpId": "rs150385342",
          "call": "C|C",
          "alleles": [
            "c.313G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97740410,
          "dbSnpId": "rs72549309",
          "call": "GATGA|GATGA",
          "alleles": [
            "c.295_298delTCAT (*7)"
          ],
          "phased": true,
          "wildtypeAllele": "GATGA",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97883329,
          "dbSnpId": "rs1801265",
          "call": "A|A",
          "alleles": [
            "c.85T>C (*9A)"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97883352,
          "dbSnpId": "rs80081766",
          "call": "C|C",
          "alleles": [
            "c.62G>A"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97883353,
          "dbSnpId": "rs72549310",
          "call": "G|G",
          "alleles": [
            "c.61C>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97883368,
          "dbSnpId": "rs150036960",
          "call": "G|G",
          "alleles": [
            "c.46C>G"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "extra-position-notes": [],
      "hasUncalledHaps": false,
      "messages": [],
      "unphased": false
    },
    {
      "diplotypes": [
        "B (wildtype)/B (wildtype)"
      ],
      "gene": "G6PD",
      "hasUncalledHaps": false,
      "variantsOfInterestUnspecified": true,
      "outsideCall": true,
      "variantsUnspecified": true,
      "messages": [],
      "totalMissingVariants": 0,
      "totalVariants": 0,
      "phaseStatus": "Unavailable for calls made outside PharmCAT",
      "unphased": false,
      "extra-position-notes": []
    },
    {
      "diplotypes": [
        "rs12979860 reference (C)/rs12979860 reference (C)"
      ],
      "gene": "IFNL3/4",
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "warnings": [
        "The IFNL3 gene is on the negative chromosomal strand, all genotype calls for IFNL3 in this report refer to the positive chromosomal strand.  Therefore, genotype calls are complemented from gene bases."
      ],
      "totalMissingVariants": 0,
      "totalVariants": 1,
      "variants": [
        {
          "gene": "IFNL3",
          "chromosome": "chr19",
          "position": 39248147,
          "dbSnpId": "rs12979860",
          "call": "C|C",
          "alleles": [
            "rs12979860 variant (T)"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "extra-position-notes": [],
      "hasUncalledHaps": false,
      "messages": [],
      "unphased": false
    },
    {
      "diplotypes": [
        "1555A>G"
      ],
      "gene": "MT-RNR1",
      "hasUncalledHaps": false,
      "variantsOfInterestUnspecified": true,
      "outsideCall": true,
      "variantsUnspecified": true,
      "messages": [],
      "totalMissingVariants": 0,
      "totalVariants": 0,
      "phaseStatus": "Unavailable for calls made outside PharmCAT",
      "unphased": false,
      "extra-position-notes": []
    },
    {
      "diplotypes": [
        "*1/*1"
      ],
      "gene": "NUDT15",
      "hasUncalledHaps": false,
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "messages": [],
      "totalMissingVariants": 0,
      "totalVariants": 17,
      "variants": [
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037748,
          "dbSnpId": "rs769369441",
          "call": "T|T",
          "alleles": [
            "*10"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037749,
          "dbSnpId": null,
          "call": "G|G",
          "alleles": [
            "*19"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037782,
          "dbSnpId": "rs746071566",
          "call": "AGGAGTC|AGGAGTC",
          "alleles": [
            "*2",
            "*6",
            "*9"
          ],
          "phased": true,
          "wildtypeAllele": "AGGAGTC",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037798,
          "dbSnpId": "rs186364861",
          "call": "G|G",
          "alleles": [
            "*5"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037825,
          "dbSnpId": "rs777311140",
          "call": "C|C",
          "alleles": [
            "*14"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037834,
          "dbSnpId": "rs1202487323",
          "call": "C|C",
          "alleles": [
            "*16"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037847,
          "dbSnpId": "rs766023281",
          "call": "G|G",
          "alleles": [
            "*7"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037849,
          "dbSnpId": null,
          "call": "A|A",
          "alleles": [
            "*8"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037885,
          "dbSnpId": "rs1950545307",
          "call": "G|G",
          "alleles": [
            "*11"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037902,
          "dbSnpId": "rs149436418",
          "call": "C|C",
          "alleles": [
            "*12"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48040977,
          "dbSnpId": "rs1457579126",
          "call": "GA|GA",
          "alleles": [
            "*18"
          ],
          "phased": true,
          "wildtypeAllele": "GA",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48041103,
          "dbSnpId": "rs761191455",
          "call": "T|T",
          "alleles": [
            "*13"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48041113,
          "dbSnpId": "rs1368252918",
          "call": "G|G",
          "alleles": [
            "*17"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48045690,
          "dbSnpId": "rs768324690",
          "call": "C|C",
          "alleles": [
            "*20"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48045719,
          "dbSnpId": "rs116855232",
          "call": "C|C",
          "alleles": [
            "*2",
            "*3"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48045720,
          "dbSnpId": "rs147390019",
          "call": "G|G",
          "alleles": [
            "*4"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48045771,
          "dbSnpId": "rs139551410",
          "call": "T|T",
          "alleles": [
            "*15"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "unphased": false,
      "extra-position-notes": []
    },
    {
      "diplotypes": [
        "Reference/Reference"
      ],
      "gene": "RYR1",
      "hasUncalledHaps": false,
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "messages": [],
      "totalMissingVariants": 0,
      "totalVariants": 44,
      "variants": [
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38440802,
          "dbSnpId": "rs193922747",
          "call": "T|T",
          "alleles": [
            "c.103T>C"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38440829,
          "dbSnpId": "rs193922748",
          "call": "C|C",
          "alleles": [
            "c.130C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38444211,
          "dbSnpId": "rs118192161",
          "call": "C|C",
          "alleles": [
            "c.487C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38444212,
          "dbSnpId": "rs193922753",
          "call": "G|G",
          "alleles": [
            "c.488G>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38446710,
          "dbSnpId": "rs1801086",
          "call": "G|G",
          "alleles": [
            "c.742G>A",
            "c.742G>C"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38448673,
          "dbSnpId": "rs193922762",
          "call": "C|C",
          "alleles": [
            "c.982C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38448712,
          "dbSnpId": "rs121918592",
          "call": "G|G",
          "alleles": [
            "c.1021G>A",
            "c.1021G>C"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38451842,
          "dbSnpId": "rs193922764",
          "call": "C|C",
          "alleles": [
            "c.1201C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38451850,
          "dbSnpId": "rs118192116",
          "call": "C|C",
          "alleles": [
            "c.1209C>G"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38455359,
          "dbSnpId": "rs118192162",
          "call": "A|A",
          "alleles": [
            "c.1565A>C"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38455463,
          "dbSnpId": "rs111888148",
          "call": "G|G",
          "alleles": [
            "c.1589G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38455471,
          "dbSnpId": "rs193922768",
          "call": "C|C",
          "alleles": [
            "c.1597C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38455472,
          "dbSnpId": "rs144336148",
          "call": "G|G",
          "alleles": [
            "c.1598G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38455528,
          "dbSnpId": "rs193922770",
          "call": "C|C",
          "alleles": [
            "c.1654C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38457545,
          "dbSnpId": "rs118192172",
          "call": "C|C",
          "alleles": [
            "c.1840C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38457546,
          "dbSnpId": "rs193922772",
          "call": "G|G",
          "alleles": [
            "c.1841G>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38494564,
          "dbSnpId": "rs118192175",
          "call": "C|C",
          "alleles": [
            "c.6487C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38494565,
          "dbSnpId": "rs118192163",
          "call": "G|G",
          "alleles": [
            "c.6488G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38494579,
          "dbSnpId": "rs118192176",
          "call": "G|G",
          "alleles": [
            "c.6502G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38496283,
          "dbSnpId": "rs118192177",
          "call": "C|C",
          "alleles": [
            "c.6617C>G",
            "c.6617C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499223,
          "dbSnpId": "rs112563513",
          "call": "G|G",
          "alleles": [
            "c.7007G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499644,
          "dbSnpId": "rs121918596",
          "call": "TGGA|TGGA",
          "alleles": [
            "c.7042_7044delGAG"
          ],
          "phased": true,
          "wildtypeAllele": "TGGA",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499655,
          "dbSnpId": "rs193922802",
          "call": "G|G",
          "alleles": [
            "c.7048G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499670,
          "dbSnpId": "rs193922803",
          "call": "C|C",
          "alleles": [
            "c.7063C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499731,
          "dbSnpId": "rs193922807",
          "call": "G|G",
          "alleles": [
            "c.7124G>C"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499975,
          "dbSnpId": "rs193922809",
          "call": "G|G",
          "alleles": [
            "c.7282G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499993,
          "dbSnpId": "rs121918593",
          "call": "G|G",
          "alleles": [
            "c.7300G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499997,
          "dbSnpId": "rs28933396",
          "call": "G|G",
          "alleles": [
            "c.7304G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500636,
          "dbSnpId": "rs118192124",
          "call": "C|C",
          "alleles": [
            "c.7354C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500642,
          "dbSnpId": "rs193922816",
          "call": "C|C",
          "alleles": [
            "c.7360C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500643,
          "dbSnpId": "rs118192122",
          "call": "G|G",
          "alleles": [
            "c.7361G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500654,
          "dbSnpId": "rs28933397",
          "call": "C|C",
          "alleles": [
            "c.7372C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500655,
          "dbSnpId": "rs121918594",
          "call": "G|G",
          "alleles": [
            "c.7373G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500898,
          "dbSnpId": "rs118192178",
          "call": "C|C",
          "alleles": [
            "c.7522C>G",
            "c.7522C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500899,
          "dbSnpId": "rs193922818",
          "call": "G|G",
          "alleles": [
            "c.7523G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38512321,
          "dbSnpId": "rs193922832",
          "call": "G|G",
          "alleles": [
            "c.9310G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38543832,
          "dbSnpId": "rs193922843",
          "call": "G|G",
          "alleles": [
            "c.11969G>T"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38580004,
          "dbSnpId": "rs118192167",
          "call": "A|A",
          "alleles": [
            "c.14387A>G"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38580094,
          "dbSnpId": "rs121918595",
          "call": "C|C",
          "alleles": [
            "c.14477C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38580114,
          "dbSnpId": "rs193922876",
          "call": "C|C",
          "alleles": [
            "c.14497C>T"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38580370,
          "dbSnpId": "rs193922878",
          "call": "C|C",
          "alleles": [
            "c.14512C>G"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38580403,
          "dbSnpId": "rs118192168",
          "call": "G|G",
          "alleles": [
            "c.14545G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38580440,
          "dbSnpId": "rs63749869",
          "call": "G|G",
          "alleles": [
            "c.14582G>A"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38584989,
          "dbSnpId": "rs118192170",
          "call": "T|T",
          "alleles": [
            "c.14693T>C"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "unphased": false,
      "extra-position-notes": []
    },
    {
      "diplotypes": [
        "*1/*1",
        "rs4149056T/rs4149056T"
      ],
      "gene": "SLCO1B1",
      "hasUncalledHaps": false,
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "messages": [],
      "totalMissingVariants": 0,
      "totalVariants": 31,
      "variants": [
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21172734,
          "dbSnpId": "rs139257324",
          "call": "C|C",
          "alleles": [
            "*33"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21172776,
          "dbSnpId": "rs373327528",
          "call": "G|G",
          "alleles": [
            "*23"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21172782,
          "dbSnpId": "rs56101265",
          "call": "T|T",
          "alleles": [
            "*2",
            "*12"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21174595,
          "dbSnpId": "rs56061388",
          "call": "T|T",
          "alleles": [
            "*3",
            "*13"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21176804,
          "dbSnpId": "rs2306283",
          "call": "A|A",
          "alleles": [
            "*14",
            "*15",
            "*20",
            "*24",
            "*25",
            "*27",
            "*28",
            "*29",
            "*30",
            "*31",
            "*32",
            "*33",
            "*37",
            "*39",
            "*42",
            "*43",
            "*44",
            "*46",
            "*47"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21176868,
          "dbSnpId": "rs2306282",
          "call": "A|A",
          "alleles": [
            "*16"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21176871,
          "dbSnpId": null,
          "call": "G|G",
          "alleles": [
            "*38"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21176879,
          "dbSnpId": "rs11045819",
          "call": "C|C",
          "alleles": [
            "*4",
            "*14",
            "*25",
            "*32",
            "*43"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21176883,
          "dbSnpId": "rs72559745",
          "call": "A|A",
          "alleles": [
            "*3",
            "*13"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21176898,
          "dbSnpId": "rs77271279",
          "call": "G|G",
          "alleles": [
            "*41"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21178612,
          "dbSnpId": "rs141467543",
          "call": "A|A",
          "alleles": [
            "*42"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21178615,
          "dbSnpId": "rs4149056",
          "call": "T|T",
          "alleles": [
            "*5",
            "*15",
            "*40",
            "*46",
            "*47"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21178957,
          "dbSnpId": "rs79135870",
          "call": "A|A",
          "alleles": [
            "*30"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21196951,
          "dbSnpId": "rs11045852",
          "call": "A|A",
          "alleles": [
            "*24",
            "*25",
            "*28",
            "*32",
            "*33",
            "*43",
            "*44"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21196975,
          "dbSnpId": "rs183501729",
          "call": "C|C",
          "alleles": [
            "*39"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21196976,
          "dbSnpId": "rs11045853",
          "call": "G|G",
          "alleles": [
            "*25",
            "*28",
            "*33"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21200544,
          "dbSnpId": "rs72559747",
          "call": "C|C",
          "alleles": [
            "*47"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21200595,
          "dbSnpId": "rs55901008",
          "call": "T|T",
          "alleles": [
            "*6"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21202553,
          "dbSnpId": "rs1228465562",
          "call": "T|T",
          "alleles": [
            "*36"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21202555,
          "dbSnpId": "rs59113707",
          "call": "C|C",
          "alleles": [
            "*27"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21202649,
          "dbSnpId": "rs56387224",
          "call": "A|A",
          "alleles": [
            "*7"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21202664,
          "dbSnpId": "rs142965323",
          "call": "G|G",
          "alleles": [
            "*26"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21205921,
          "dbSnpId": "rs72559748",
          "call": "A|A",
          "alleles": [
            "*8"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21205999,
          "dbSnpId": "rs59502379",
          "call": "G|G",
          "alleles": [
            "*9",
            "*31"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21206031,
          "dbSnpId": "rs74064213",
          "call": "A|A",
          "alleles": [
            "*43",
            "*44"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21222355,
          "dbSnpId": "rs71581941",
          "call": "C|C",
          "alleles": [
            "*45",
            "*46"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21239042,
          "dbSnpId": "rs34671512",
          "call": "A|A",
          "alleles": [
            "*19",
            "*20",
            "*40"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21239077,
          "dbSnpId": "rs56199088",
          "call": "A|A",
          "alleles": [
            "*10",
            "*12"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21239113,
          "dbSnpId": "rs55737008",
          "call": "A|A",
          "alleles": [
            "*11",
            "*13"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21239145,
          "dbSnpId": "rs200995543",
          "call": "C|C",
          "alleles": [
            "*34"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21239158,
          "dbSnpId": "rs140790673",
          "call": "C|C",
          "alleles": [
            "*29"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "unphased": false,
      "extra-position-notes": []
    },
    {
      "diplotypes": [
        "*1/*1"
      ],
      "gene": "TPMT",
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "warnings": [
        "The TPMT gene is on the negative chromosomal strand, all genotype calls for TPMT in this report refer to the positive chromosomal strand.  Therefore, genotype calls are complemented from gene bases."
      ],
      "totalMissingVariants": 0,
      "totalVariants": 43,
      "variants": [
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130687,
          "dbSnpId": "rs1142345",
          "call": "T|T",
          "alleles": [
            "*3A",
            "*3C",
            "*41"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130694,
          "dbSnpId": "rs150900439",
          "call": "T|T",
          "alleles": [
            "*20"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130725,
          "dbSnpId": "rs72552736",
          "call": "A|A",
          "alleles": [
            "*7"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130729,
          "dbSnpId": "rs139392616",
          "call": "C|C",
          "alleles": [
            "*40"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130758,
          "dbSnpId": "rs398122996",
          "call": "A|A",
          "alleles": [
            "*37"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130762,
          "dbSnpId": "rs56161402",
          "call": "C|C",
          "alleles": [
            "*8"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130772,
          "dbSnpId": "rs377085266",
          "call": "A|A",
          "alleles": [
            "*25"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130781,
          "dbSnpId": "rs1800584",
          "call": "C|C",
          "alleles": [
            "*4"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18132136,
          "dbSnpId": "rs72556347",
          "call": "A|A",
          "alleles": [
            "*26"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18132147,
          "dbSnpId": "rs79901429",
          "call": "A|A",
          "alleles": [
            "*31"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18132163,
          "dbSnpId": null,
          "call": "C|C",
          "alleles": [
            "*36"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18133845,
          "dbSnpId": "rs75543815",
          "call": "T|T",
          "alleles": [
            "*6"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18133847,
          "dbSnpId": "rs6921269",
          "call": "C|C",
          "alleles": [
            "*24"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18133870,
          "dbSnpId": "rs772832951",
          "call": "A|A",
          "alleles": [
            "*38"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18133884,
          "dbSnpId": "rs74423290",
          "call": "G|G",
          "alleles": [
            "*23"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18133887,
          "dbSnpId": "rs201695576",
          "call": "T|T",
          "alleles": [
            "*44"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18133890,
          "dbSnpId": "rs9333570",
          "call": "C|C",
          "alleles": [
            "*15"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18138969,
          "dbSnpId": "rs144041067",
          "call": "C|C",
          "alleles": [
            "*16",
            "*22"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18138970,
          "dbSnpId": "rs112339338",
          "call": "G|G",
          "alleles": [
            "*33"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18138997,
          "dbSnpId": "rs1800460",
          "call": "C|C",
          "alleles": [
            "*3A",
            "*3B"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18139027,
          "dbSnpId": "rs72552737",
          "call": "C|C",
          "alleles": [
            "*10"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18139689,
          "dbSnpId": "rs72552738",
          "call": "C|C",
          "alleles": [
            "*11"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18139710,
          "dbSnpId": "rs200220210",
          "call": "G|G",
          "alleles": [
            "*12"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143597,
          "dbSnpId": null,
          "call": "T|T",
          "alleles": [
            "*19"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143606,
          "dbSnpId": "rs151149760",
          "call": "T|T",
          "alleles": [
            "*9"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143613,
          "dbSnpId": null,
          "call": "C|C",
          "alleles": [
            "*28"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143622,
          "dbSnpId": "rs115106679",
          "call": "C|C",
          "alleles": [
            "*32"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143643,
          "dbSnpId": null,
          "call": "A|A",
          "alleles": [
            "*27"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143700,
          "dbSnpId": "rs753545734",
          "call": "C|C",
          "alleles": [
            "*43"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143718,
          "dbSnpId": "rs111901354",
          "call": "G|G",
          "alleles": [
            "*34"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143724,
          "dbSnpId": "rs1800462",
          "call": "C|C",
          "alleles": [
            "*2"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143728,
          "dbSnpId": "rs1256618794",
          "call": "C|C",
          "alleles": [
            "*43"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18147838,
          "dbSnpId": "rs281874771",
          "call": "G|G",
          "alleles": [
            "*39"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18147845,
          "dbSnpId": "rs777686348",
          "call": "C|C",
          "alleles": [
            "*18"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18147851,
          "dbSnpId": "rs200591577",
          "call": "G|G",
          "alleles": [
            "*21"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18147856,
          "dbSnpId": null,
          "call": "A|A",
          "alleles": [
            "*35"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18147910,
          "dbSnpId": "rs72552740",
          "call": "A|A",
          "alleles": [
            "*5"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18149004,
          "dbSnpId": null,
          "call": "G|G",
          "alleles": [
            "*17"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18149022,
          "dbSnpId": "rs750424422",
          "call": "C|C",
          "alleles": [
            "*30"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18149032,
          "dbSnpId": "rs759836180",
          "call": "C|C",
          "alleles": [
            "*42"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18149045,
          "dbSnpId": "rs72552742",
          "call": "T|T",
          "alleles": [
            "*13"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18149126,
          "dbSnpId": "rs267607275",
          "call": "A|A",
          "alleles": [
            "*29"
          ],
          "phased": true,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18149127,
          "dbSnpId": "rs9333569",
          "call": "T|T",
          "alleles": [
            "*14"
          ],
          "phased": true,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "extra-position-notes": [],
      "hasUncalledHaps": false,
      "messages": [],
      "unphased": false
    },
    {
      "diplotypes": [
        "*1/*1"
      ],
      "gene": "UGT1A1",
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "warnings": [
        "Some alleles in UGT1A1 are distinguished by a repeat sequence; some genotyping technologies may not accurately call the repeat."
      ],
      "totalMissingVariants": 0,
      "totalVariants": 4,
      "variants": [
        {
          "gene": "UGT1A1",
          "chromosome": "chr2",
          "position": 233759924,
          "dbSnpId": "rs887829",
          "call": "C|C",
          "alleles": [
            "*80",
            "*80+*28",
            "*80+*37"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "UGT1A1",
          "chromosome": "chr2",
          "position": 233760233,
          "dbSnpId": "rs3064744",
          "call": "CAT|CAT",
          "alleles": [
            "*28",
            "*36",
            "*37",
            "*80+*28",
            "*80+*37"
          ],
          "phased": true,
          "wildtypeAllele": "CAT",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "UGT1A1",
          "chromosome": "chr2",
          "position": 233760498,
          "dbSnpId": "rs4148323",
          "call": "G|G",
          "alleles": [
            "*6"
          ],
          "phased": true,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "UGT1A1",
          "chromosome": "chr2",
          "position": 233760973,
          "dbSnpId": "rs35350960",
          "call": "C|C",
          "alleles": [
            "*27"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "extra-position-notes": [],
      "hasUncalledHaps": false,
      "messages": [],
      "unphased": false
    },
    {
      "diplotypes": [
        "rs9923231 reference (C)/rs9923231 reference (C)"
      ],
      "gene": "VKORC1",
      "variantsOfInterestUnspecified": true,
      "outsideCall": false,
      "warnings": [
        "CPIC recommendations for warfarin use only rs9923231; however, other variants in VKORC1 may have functional consequences and may be more common in some populations.",
        "The VKORC1 gene is on the negative chromosomal strand, all genotype calls for VKORC1 in this report refer to the positive chromosomal strand.  Therefore, genotype calls are complemented from gene bases."
      ],
      "totalMissingVariants": 0,
      "totalVariants": 1,
      "variants": [
        {
          "gene": "VKORC1",
          "chromosome": "chr16",
          "position": 31096368,
          "dbSnpId": "rs9923231",
          "call": "C|C",
          "alleles": [
            "rs9923231 variant (T)"
          ],
          "phased": true,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        }
      ],
      "phaseStatus": "Phased",
      "extra-position-notes": [],
      "hasUncalledHaps": false,
      "messages": [],
      "unphased": false
    }
  ],
  "calledGenes": 19,
  "cpicVersion": "v1.14",
  "genotypes": [
    {
      "phenotype": [
        "Normal Function"
      ],
      "called": true,
      "functions": [
        "Two normal function alleles"
      ],
      "gene": "ABCG2",
      "drugs": [
        {
          "name": "rosuvastatin",
          "guidelineId": "RxNorm:301542"
        }
      ],
      "calls": [
        "rs2231142 reference (G)/rs2231142 reference (G)"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": false
    },
    {
      "phenotype": [
        "Uncertain Susceptibility"
      ],
      "called": true,
      "functions": [
        "Two normal function alleles"
      ],
      "gene": "CACNA1S",
      "drugs": [
        {
          "name": "desflurane",
          "guidelineId": "RxNorm:27340"
        },
        {
          "name": "enflurane",
          "guidelineId": "RxNorm:3920"
        },
        {
          "name": "halothane",
          "guidelineId": "RxNorm:5095"
        },
        {
          "name": "isoflurane",
          "guidelineId": "RxNorm:6026"
        },
        {
          "name": "methoxyflurane",
          "guidelineId": "RxNorm:6857"
        },
        {
          "name": "sevoflurane",
          "guidelineId": "RxNorm:36453"
        },
        {
          "name": "succinylcholine",
          "guidelineId": "RxNorm:10154"
        }
      ],
      "calls": [
        "Reference/Reference"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": false
    },
    {
      "phenotype": [
        "ivacaftor non-responsive in CF patients"
      ],
      "called": true,
      "functions": [
        "Two ivacaftor non-responsive alleles"
      ],
      "gene": "CFTR",
      "drugs": [
        {
          "name": "ivacaftor",
          "guidelineId": "RxNorm:1243041"
        }
      ],
      "calls": [
        "No CPIC variants found"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": false
    },
    {
      "phenotype": [
        "Normal Metabolizer"
      ],
      "called": true,
      "functions": [
        "Two normal function alleles"
      ],
      "gene": "CYP2B6",
      "drugs": [
        {
          "name": "efavirenz",
          "guidelineId": "RxNorm:195085"
        }
      ],
      "calls": [
        "*1/*1"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": false
    },
    {
      "phenotype": [
        "Normal Metabolizer"
      ],
      "called": true,
      "functions": [
        "Two normal function alleles"
      ],
      "gene": "CYP2C19",
      "drugs": [
        {
          "name": "amitriptyline",
          "guidelineId": "RxNorm:704"
        },
        {
          "name": "citalopram",
          "guidelineId": "RxNorm:2556"
        },
        {
          "name": "clomipramine",
          "guidelineId": "RxNorm:2597"
        },
        {
          "name": "clopidogrel",
          "guidelineId": "RxNorm:32968"
        },
        {
          "name": "dexlansoprazole",
          "guidelineId": "RxNorm:816346"
        },
        {
          "name": "doxepin",
          "guidelineId": "RxNorm:3638"
        },
        {
          "name": "escitalopram",
          "guidelineId": "RxNorm:321988"
        },
        {
          "name": "imipramine",
          "guidelineId": "RxNorm:5691"
        },
        {
          "name": "lansoprazole",
          "guidelineId": "RxNorm:17128"
        },
        {
          "name": "omeprazole",
          "guidelineId": "RxNorm:7646"
        },
        {
          "name": "pantoprazole",
          "guidelineId": "RxNorm:40790"
        },
        {
          "name": "sertraline",
          "guidelineId": "RxNorm:36437"
        },
        {
          "name": "trimipramine",
          "guidelineId": "RxNorm:10834"
        },
        {
          "name": "voriconazole",
          "guidelineId": "RxNorm:121243"
        }
      ],
      "calls": [
        "*38/*38"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": false
    },
    {
      "phenotype": [
        "Normal Metabolizer"
      ],
      "called": true,
      "functions": [
        "Two normal function alleles"
      ],
      "gene": "CYP2C9",
      "drugs": [
        {
          "name": "celecoxib",
          "guidelineId": "RxNorm:140587"
        },
        {
          "name": "flurbiprofen",
          "guidelineId": "RxNorm:4502"
        },
        {
          "name": "fluvastatin",
          "guidelineId": "RxNorm:41127"
        },
        {
          "name": "ibuprofen",
          "guidelineId": "RxNorm:5640"
        },
        {
          "name": "lornoxicam",
          "guidelineId": "RxNorm:20890"
        },
        {
          "name": "meloxicam",
          "guidelineId": "RxNorm:41493"
        },
        {
          "name": "piroxicam",
          "guidelineId": "RxNorm:8356"
        },
        {
          "name": "tenoxicam",
          "guidelineId": "RxNorm:37790"
        },
        {
          "name": "warfarin",
          "guidelineId": "RxNorm:11289"
        }
      ],
      "calls": [
        "*1/*1"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": false
    },
    {
      "phenotype": [
        "Intermediate Metabolizer"
      ],
      "called": true,
      "functions": [
        "One no function allele and one normal function allele"
      ],
      "gene": "CYP2D6",
      "drugs": [
        {
          "name": "amitriptyline",
          "guidelineId": "RxNorm:704"
        },
        {
          "name": "atomoxetine",
          "guidelineId": "RxNorm:38400"
        },
        {
          "name": "clomipramine",
          "guidelineId": "RxNorm:2597"
        },
        {
          "name": "codeine",
          "guidelineId": "RxNorm:2670"
        },
        {
          "name": "desipramine",
          "guidelineId": "RxNorm:3247"
        },
        {
          "name": "doxepin",
          "guidelineId": "RxNorm:3638"
        },
        {
          "name": "fluvoxamine",
          "guidelineId": "RxNorm:42355"
        },
        {
          "name": "hydrocodone",
          "guidelineId": "RxNorm:5489"
        },
        {
          "name": "imipramine",
          "guidelineId": "RxNorm:5691"
        },
        {
          "name": "nortriptyline",
          "guidelineId": "RxNorm:7531"
        },
        {
          "name": "ondansetron",
          "guidelineId": "RxNorm:26225"
        },
        {
          "name": "paroxetine",
          "guidelineId": "RxNorm:32937"
        },
        {
          "name": "tamoxifen",
          "guidelineId": "RxNorm:10324"
        },
        {
          "name": "tramadol",
          "guidelineId": "RxNorm:10689"
        },
        {
          "name": "trimipramine",
          "guidelineId": "RxNorm:10834"
        },
        {
          "name": "tropisetron",
          "guidelineId": "RxNorm:27392"
        }
      ],
      "calls": [
        "*1/*3"
      ],
      "missingVariants": "N/A",
      "outsideCall": true,
      "unphased": false,
      "hasMessages": true
    },
    {
      "phenotype": [
        "Normal Metabolizer"
      ],
      "called": true,
      "functions": [
        "Two normal function alleles"
      ],
      "gene": "CYP3A5",
      "drugs": [
        {
          "name": "tacrolimus",
          "guidelineId": "RxNorm:42316"
        }
      ],
      "calls": [
        "*1/*1"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": true
    },
    {
      "phenotype": [
        "N/A"
      ],
      "called": true,
      "functions": [
        "N/A"
      ],
      "gene": "CYP4F2",
      "drugs": [
        {
          "name": "warfarin",
          "guidelineId": "RxNorm:11289"
        }
      ],
      "calls": [
        "*1/*1"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": false
    },
    {
      "phenotype": [
        "Normal Metabolizer"
      ],
      "called": true,
      "functions": [
        "Two normal function alleles"
      ],
      "gene": "DPYD",
      "drugs": [
        {
          "name": "capecitabine",
          "guidelineId": "RxNorm:194000"
        },
        {
          "name": "fluorouracil",
          "guidelineId": "RxNorm:4492"
        }
      ],
      "calls": [
        "Reference/Reference"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": true
    },
    {
      "phenotype": [
        "Normal"
      ],
      "called": true,
      "functions": [
        "Two normal function alleles"
      ],
      "gene": "G6PD",
      "drugs": [
        {
          "name": "rasburicase",
          "guidelineId": "RxNorm:283821"
        }
      ],
      "calls": [
        "B (wildtype)/B (wildtype)"
      ],
      "missingVariants": "N/A",
      "outsideCall": true,
      "unphased": false,
      "hasMessages": false
    },
    {
      "phenotype": [
        "N/A"
      ],
      "called": true,
      "functions": [
        "N/A"
      ],
      "gene": "IFNL3/4",
      "drugs": [
        {
          "name": "peginterferon alfa-2a",
          "guidelineId": "RxNorm:120608"
        },
        {
          "name": "peginterferon alfa-2b",
          "guidelineId": "RxNorm:253453"
        }
      ],
      "calls": [
        "rs12979860 reference (C)/rs12979860 reference (C)"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": true
    },
    {
      "phenotype": [
        "increased risk of aminoglycoside-induced hearing loss"
      ],
      "called": true,
      "functions": [
        "increased risk of aminoglycoside-induced hearing loss"
      ],
      "gene": "MT-RNR1",
      "drugs": [
        {
          "name": "amikacin",
          "guidelineId": "RxNorm:641"
        },
        {
          "name": "gentamicin",
          "guidelineId": "ATC:D06AX07"
        },
        {
          "name": "kanamycin",
          "guidelineId": "RxNorm:6099"
        },
        {
          "name": "paromomycin",
          "guidelineId": "RxNorm:7934"
        },
        {
          "name": "plazomicin",
          "guidelineId": "RxNorm:2049549"
        },
        {
          "name": "streptomycin",
          "guidelineId": "RxNorm:10109"
        },
        {
          "name": "tobramycin",
          "guidelineId": "RxNorm:10627"
        }
      ],
      "calls": [
        "1555A>G"
      ],
      "missingVariants": "N/A",
      "outsideCall": true,
      "unphased": false,
      "hasMessages": false
    },
    {
      "phenotype": [
        "Normal Metabolizer"
      ],
      "called": true,
      "functions": [
        "Two normal function alleles"
      ],
      "gene": "NUDT15",
      "drugs": [
        {
          "name": "azathioprine",
          "guidelineId": "RxNorm:1256"
        },
        {
          "name": "mercaptopurine",
          "guidelineId": "RxNorm:103"
        },
        {
          "name": "thioguanine",
          "guidelineId": "RxNorm:10485"
        }
      ],
      "calls": [
        "*1/*1"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": false
    },
    {
      "phenotype": [
        "Uncertain Susceptibility"
      ],
      "called": true,
      "functions": [
        "Two normal function alleles"
      ],
      "gene": "RYR1",
      "drugs": [
        {
          "name": "desflurane",
          "guidelineId": "RxNorm:27340"
        },
        {
          "name": "enflurane",
          "guidelineId": "RxNorm:3920"
        },
        {
          "name": "halothane",
          "guidelineId": "RxNorm:5095"
        },
        {
          "name": "isoflurane",
          "guidelineId": "RxNorm:6026"
        },
        {
          "name": "methoxyflurane",
          "guidelineId": "RxNorm:6857"
        },
        {
          "name": "sevoflurane",
          "guidelineId": "RxNorm:36453"
        },
        {
          "name": "succinylcholine",
          "guidelineId": "RxNorm:10154"
        }
      ],
      "calls": [
        "Reference/Reference"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": false
    },
    {
      "phenotype": [
        "Normal Function"
      ],
      "called": true,
      "functions": [
        "Two normal function alleles"
      ],
      "gene": "SLCO1B1",
      "drugs": [
        {
          "name": "atorvastatin",
          "guidelineId": "RxNorm:83367"
        },
        {
          "name": "fluvastatin",
          "guidelineId": "RxNorm:41127"
        },
        {
          "name": "lovastatin",
          "guidelineId": "RxNorm:6472"
        },
        {
          "name": "pitavastatin",
          "guidelineId": "RxNorm:861634"
        },
        {
          "name": "pravastatin",
          "guidelineId": "RxNorm:42463"
        },
        {
          "name": "rosuvastatin",
          "guidelineId": "RxNorm:301542"
        },
        {
          "name": "simvastatin",
          "guidelineId": "RxNorm:36567"
        }
      ],
      "calls": [
        "*1/*1"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": false
    },
    {
      "phenotype": [
        "Normal Metabolizer"
      ],
      "called": true,
      "functions": [
        "Two normal function alleles"
      ],
      "gene": "TPMT",
      "drugs": [
        {
          "name": "azathioprine",
          "guidelineId": "RxNorm:1256"
        },
        {
          "name": "mercaptopurine",
          "guidelineId": "RxNorm:103"
        },
        {
          "name": "thioguanine",
          "guidelineId": "RxNorm:10485"
        }
      ],
      "calls": [
        "*1/*1"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": true
    },
    {
      "phenotype": [
        "Normal Metabolizer"
      ],
      "called": true,
      "functions": [
        "Two normal function alleles"
      ],
      "gene": "UGT1A1",
      "drugs": [
        {
          "name": "atazanavir",
          "guidelineId": "RxNorm:343047"
        }
      ],
      "calls": [
        "*1/*1"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": true
    },
    {
      "phenotype": [
        "N/A"
      ],
      "called": true,
      "functions": [
        "N/A"
      ],
      "gene": "VKORC1",
      "drugs": [
        {
          "name": "warfarin",
          "guidelineId": "RxNorm:11289"
        }
      ],
      "calls": [
        "rs9923231 reference (C)/rs9923231 reference (C)"
      ],
      "missingVariants": "No",
      "outsideCall": false,
      "unphased": false,
      "hasMessages": true
    }
  ],
  "guidelines": [
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "MT-RNR1",
          "diplotypes": "1555A>G",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "increased risk of aminoglycoside-induced hearing loss",
          "outsideCall": true
        }
      ],
      "drugs": "amikacin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic.",
              "term": "Implication for MT-RNR1"
            },
            {
              "annotation": "MT-RNR1:1555A>G",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "increased risk of aminoglycoside-induced hearing loss",
              "term": "Phenotype for MT-RNR1"
            },
            {
              "annotation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring).",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:641",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "amitriptyline",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Reduced metabolism of TCAs to less active compounds compared to normal metabolizers; Higher plasma concentrations of active drug will increase the probability of side effects",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "Normal metabolism of tertiary amines",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38, CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Consider a 25% reduction of recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "term": "Recommendation"
            },
            {
              "annotation": "Moderate",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPICÂ®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "MÃ¼ller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "MÃ¼ller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:704",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "UGT1A1",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "atazanavir",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Reference UGT1A1 activity; very low likelihood of bilirubin-related discontinuation of atazanavir.",
              "term": "Implication for UGT1A1"
            },
            {
              "annotation": "UGT1A1:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for UGT1A1"
            },
            {
              "annotation": "There is no need to avoid prescribing of atazanavir based on UGT1A1 genetic test result. Inform the patient that some patients stop atazanavir because of jaundice (yellow eyes and skin), but that this patientâ€™s genotype makes this unlikely (less than about a 1 in 20 chance of stopping atazanavir because of jaundice).",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "All studies correlating UGT1A1 genotypes with atazanavir adverse events have involved ritonavir boosting. However, concentration-time profiles are equivalent when boosted with either cobicistat or ritonavir (PMID 23532097), and bilirubin-related adverse events including discontinuation of atazanavir occur in a similar percentage of patients prescribed atazanavir with cobicistat or ritonavir (PMID 23532097). Associations between UGT1A1 genotype, bilirubin elevations, and atazanavir/r discontinuation therefore almost certainly translate to atazanavir/cobicistat. \"reference\" function refers to the UGT1A1 allele to which other alleles are compared.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing",
          "authors": [
            "Gammal Roseann S",
            "Court Michael H",
            "Haidar Cyrine E",
            "Iwuchukwu Otito Frances",
            "Gaur Aditya H",
            "Alvarellos Maria",
            "Guillemette Chantal",
            "Lennox Jeffrey L",
            "Whirl-Carrillo Michelle",
            "Brummel Sean",
            "Ratain Mark J",
            "Klein Teri E",
            "Schackman Bruce R",
            "Caudle Kelly E",
            "Haas David W"
          ],
          "pmid": "26417955",
          "pmcid": "PMC4785051",
          "doi": "10.1002/cpt.269",
          "month": 9,
          "year": 2015
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:343047",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "atomoxetine",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "adults",
              "term": "Population"
            },
            {
              "annotation": "Possibly higher atomoxetine concentrations as compared to normal metabolizers but questionable clinical significance. Intermediate metabolizers with an activity score of 1 may be at an increased risk of discontinuation as compared to poor metabolizers.",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Initiate with a dose of 40 mg/day and increase to 80 mg/day after 3 days. If no clinical response and in the absence of adverse events after 2 weeks, consider increasing dose to 100 mg/day. If no clinical response observed after 2 weeks, consider obtaining a peak plasma concentration (1 to 2 hours after dose administered). If <200 ng/mL, consider a proportional increase in dose to approach 400 ng/mL. Dosages greater than 100 mg/day may be needed to achieve target concentrations.",
              "term": "Recommendation"
            },
            {
              "annotation": "Moderate",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Therapeutic range of 200 to 1000 ng/mL has been proposed (PMID 29493375). Limited data are available regarding the relationship between atomoxetine plasma concentrations and clinical response. Available information suggests that clinical response is greater in poor metabolizers (PMs) compared to non-PMs and may be related to the higher plasma concentrations 1 to 1.5 hours after dosing in PMs compared to non-PMs administered a similar dose. Furthermore, modest improvement in response, defined as reduction in ADHD-rating scale, is observed at peak concentrations greater than 400 ng/mL. Doses above 120 mg/day have not been evaluated.",
              "term": "Comments"
            }
          ]
        },
        {
          "annotations": [
            {
              "annotation": "pediatrics",
              "term": "Population"
            },
            {
              "annotation": "Possibly higher atomoxetine concentrations as compared to normal metabolizers but questionable clinical significance. Intermediate metabolizers with an activity score of 1 may be at an increased risk of discontinuation as compared to poor metabolizers.",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Initiate with a dose of 0.5 mg/kg/day and increase to 1.2 mg/kg/day after 3 days. If no clinical response and in the absence of adverse events after 2 weeks, consider obtaining a peak plasma concentration (1 to 2 hours after dose administered). If < 200 ng/mL, consider a proportional increase in dose to approach 400 ng/mL.",
              "term": "Recommendation"
            },
            {
              "annotation": "Moderate",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Therapeutic range of 200 to 1000 ng/mL has been proposed (PMID 29493375). Limited data are available regarding the relationship between atomoxetine plasma concentrations and clinical response. Available information suggests that clinical response is greater in poor metabolizers (PMs) compared to non-PMs and may be related to the higher plasma concentrations 1 to 1.5 hours after dosing in PMs compared to non-PMs administered a similar dose. Furthermore, modest improvement in response, defined as reduction in ADHD-rating scale, is observed at peak concentrations greater than 400 ng/mL.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/",
      "mutliMatch": true,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Atomoxetine Therapy.",
          "authors": [
            "Brown Jacob T",
            "Bishop Jeffrey R",
            "Sangkuhl Katrin",
            "Nurmi Erika L",
            "Mueller Daniel J",
            "Dinh Jean C",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Caudle Kelly E",
            "McCracken James T",
            "de Leon Jose",
            "Steven Leeder J"
          ],
          "pmid": "30801677",
          "pmcid": null,
          "doi": null,
          "month": 2,
          "year": 2019
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:38400",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "SLCO1B1",
          "diplotypes": "*1/*1",
          "showHighlights": true,
          "highlightedVariants": [
            "rs4149056T/rs4149056T"
          ],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "atorvastatin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "population general",
              "term": "Population"
            },
            {
              "annotation": "Typical myopathy risk and statin exposure",
              "term": "Implication for SLCO1B1"
            },
            {
              "annotation": "SLCO1B1:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Function",
              "term": "Phenotype for SLCO1B1"
            },
            {
              "annotation": "Prescribe desired starting dose and adjust doses based on disease-specific guidelines.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:83367",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "NUDT15",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "TPMT",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "azathioprine",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Lower concentrations of TGN metabolites, higher MeTIMP, this is the â€˜normalâ€™ pattern. Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression.",
              "term": "Implication for TPMT"
            },
            {
              "annotation": "Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression",
              "term": "Implication for NUDT15"
            },
            {
              "annotation": "NUDT15:*1/*1, TPMT:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for TPMT"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for NUDT15"
            },
            {
              "annotation": "Start with normal starting dose (e.g., 2-3 mg/kg/day) and adjust doses of azathioprine based on disease-specific guidelines. Allow 2 weeks to reach steady-state after each dose adjustment (PMID 20354201, 11302950, 15606506).",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Normal starting doses vary by race/ethnicity and treatment regimens. If standard dose is below normal recommended dose, dose reduction might not be recommended for intermediate metabolizers.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Klein T E"
          ],
          "pmid": "21270794",
          "pmcid": "PMC3098761",
          "doi": "10.1038/clpt.2010.320",
          "month": 3,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Hicks J K",
            "Schwab M",
            "Klein T E"
          ],
          "pmid": "23422873",
          "pmcid": "PMC3604643",
          "doi": "10.1038/clpt.2013.4",
          "month": 1,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update.",
          "authors": [
            "Relling Mary V",
            "Schwab Matthias",
            "Whirl-Carrillo Michelle",
            "Suarez-Kurtz Guilherme",
            "Pui Ching-Hon",
            "Stein Charles M",
            "Moyer Ann M",
            "Evans William E",
            "Klein Teri E",
            "Antillon-Klussmann Federico Guillermo",
            "Caudle Kelly E",
            "Kato Motohiro",
            "Yeoh Allen E J",
            "Schmiegelow Kjeld",
            "Yang Jun J"
          ],
          "pmid": "30447069",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:1256",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "DPYD",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "capecitabine",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal DPD activity and \"normal\" risk for fluoropyrimidine toxicity",
              "term": "Implication for DPYD"
            },
            {
              "annotation": "DPYD:Reference/Reference",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for DPYD"
            },
            {
              "annotation": "2.0",
              "term": "Activity Score for DPYD"
            },
            {
              "annotation": "Based on genotype, there is no indication to change dose or therapy. Use label-recommended dosage and administration.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing",
          "authors": [
            "Caudle Kelly E",
            "Thorn Caroline F",
            "Klein Teri E",
            "Swen Jesse J",
            "McLeod Howard L",
            "Diasio Robert B",
            "Schwab Matthias"
          ],
          "pmid": "23988873",
          "pmcid": "PMC3831181",
          "doi": "10.1038/clpt.2013.172",
          "month": 8,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update",
          "authors": [
            "Amstutz Ursula",
            "Henricks Linda M",
            "Offer Steven M",
            "Barbarino Julia",
            "Schellens Jan H M",
            "Swen Jesse J",
            "Klein Teri E",
            "McLeod Howard L",
            "Caudle Kelly E",
            "Diasio Robert B",
            "Schwab Matthias"
          ],
          "pmid": "29152729",
          "pmcid": "PMC5760397",
          "doi": "10.1002/cpt.911",
          "month": 11,
          "year": 2017
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:194000",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C9",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "celecoxib",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal metabolism",
              "term": "Implication for CYP2C9"
            },
            {
              "annotation": "CYP2C9:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C9"
            },
            {
              "annotation": "2.0",
              "term": "Activity Score for CYP2C9"
            },
            {
              "annotation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "AgÃºndez JosÃ© A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:140587",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "citalopram",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal metabolism",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "Initiate therapy with recommended starting dose",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors",
          "authors": [
            "Hicks J Kevin",
            "Bishop Jeffrey R",
            "Sangkuhl Katrin",
            "MÃ¼ller Daniel J",
            "Ji Yuan",
            "Leckband Susan G",
            "Leeder J Steven",
            "Graham Rebecca L",
            "Chiulli Dana L",
            "LLerena AdriÃ¡n",
            "Skaar Todd C",
            "Scott Stuart A",
            "Stingl Julia C",
            "Klein Teri E",
            "Caudle Kelly E",
            "Gaedigk Andrea"
          ],
          "pmid": "25974703",
          "pmcid": "PMC4512908",
          "doi": "10.1002/cpt.147",
          "month": 5,
          "year": 2015
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:2556",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "clomipramine",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Reduced metabolism of TCAs to less active compounds compared to normal metabolizers; Higher plasma concentrations of active drug will increase the probability of side effects",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "Normal metabolism of tertiary amines",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38, CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Consider a 25% reduction of recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "term": "Recommendation"
            },
            {
              "annotation": "Optional",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPICÂ®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "MÃ¼ller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "MÃ¼ller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:2597",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "clopidogrel",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "CVI non-ACS non-PCI",
              "term": "Population"
            },
            {
              "annotation": "Normal clopidogrel active metabolite formation; normal on-treatment platelet reactivity",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "If considering clopidogrel, use at standard dose (75 mg/day)",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "For non-acute coronary syndrome (non-ACS) and non-percutaneous coronary intervention (non-PCI) cardiovascular indications. Non-ACS, non-PCI cardiovascular indications include peripheral arterial disease and stable coronary artery disease following a recent myocardial infarction outside the setting of PCI.",
              "term": "Comments"
            }
          ]
        },
        {
          "annotations": [
            {
              "annotation": "CVI ACS PCI ",
              "term": "Population"
            },
            {
              "annotation": "Normal clopidogrel active metabolite formation; normal on-treatment platelet reactivity",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "If considering clopidogrel, use at standard dose (75 mg/day)",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "For cardiovascular indications of acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI). ACS and/or PCI includes patients undergoing PCI for an ACS or non-ACS (elective) indication.",
              "term": "Comments"
            }
          ]
        },
        {
          "annotations": [
            {
              "annotation": "NVI",
              "term": "Population"
            },
            {
              "annotation": "Normal clopidogrel active metabolite formation; normal on-treatment platelet reactivity",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "If considering clopidogrel, use at standard dose (75 mg/day)",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "For neurovascular indications. Neurovascular disease includes acute ischemic stroke or transient ischemic attack, secondary prevention of stroke, or prevention of thromboembolic events following neurointerventional procedures such as carotid artery stenting and stent-assisted coiling of intracranial aneurysms.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/",
      "mutliMatch": true,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy",
          "authors": [
            "Scott S A",
            "Sangkuhl K",
            "Gardner E E",
            "Stein C M",
            "Hulot J-S",
            "Johnson J A",
            "Roden D M",
            "Klein T E",
            "Shuldiner A R"
          ],
          "pmid": "21716271",
          "pmcid": "PMC3234301",
          "doi": "10.1038/clpt.2011.132",
          "month": 6,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy: 2013 Update",
          "authors": [
            "Scott Stuart A",
            "Sangkuhl Katrin",
            "Stein C Michael",
            "Hulot Jean-SÃ©bastien",
            "Mega Jessica L",
            "Roden Dan M",
            "Klein Teri E",
            "Sabatine Marc S",
            "Johnson Julie A",
            "Shuldiner Alan R"
          ],
          "pmid": "23698643",
          "pmcid": "PMC3748366",
          "doi": "10.1038/clpt.2013.105",
          "month": 5,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.",
          "authors": [
            "Lee Craig R",
            "Luzum Jasmine A",
            "Sangkuhl Katrin",
            "Gammal Roseann S",
            "Sabatine Marc S",
            "Stein C Michael",
            "Kisor David F",
            "Limdi Nita A",
            "Lee Yee Ming",
            "Scott Stuart A",
            "Hulot Jean-SÃ©bastien",
            "Roden Dan M",
            "Gaedigk Andrea",
            "Caudle Kelly E",
            "Klein Teri E",
            "Johnson Julie A",
            "Shuldiner Alan R"
          ],
          "pmid": "35034351",
          "pmcid": null,
          "doi": "10.1002/cpt.2526",
          "month": 1,
          "year": 2022
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:32968",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "codeine",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Reduced morphine formation",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "1",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Use codeine label recommended age- or weight-specific dosing. If no response and opioid use is warranted, consider a non-tramadol opioid.",
              "term": "Recommendation"
            },
            {
              "annotation": "Moderate",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype",
          "authors": [
            "Crews K R",
            "Gaedigk A",
            "Dunnenberger H M",
            "Klein T E",
            "Shen D D",
            "Callaghan J T",
            "Kharasch E D",
            "Skaar T C"
          ],
          "pmid": "22205192",
          "pmcid": "PMC3289963",
          "doi": "10.1038/clpt.2011.287",
          "month": 12,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy: 2014 Update",
          "authors": [
            "Crews Kristine R",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Leeder J Steve",
            "Klein Teri E",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Shen Danny D",
            "Callaghan John T",
            "Sadhasivam Senthilkumar",
            "Prows Cynthia A",
            "Kharasch Evan D",
            "Skaar Todd C"
          ],
          "pmid": "24458010",
          "pmcid": "PMC3975212",
          "doi": "10.1038/clpt.2013.254",
          "month": 1,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy.",
          "authors": [
            "Crews Kristine R",
            "Monte Andrew A",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Kharasch Evan D",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Leeder J Steven",
            "Callaghan John T",
            "Samer Caroline Flora",
            "Klein Teri E",
            "Haidar Cyrine E",
            "Van Driest Sara L",
            "Ruano Gualberto",
            "Sangkuhl Katrin",
            "Cavallari Larisa H",
            "MÃ¼ller Daniel J",
            "Prows Cynthia A",
            "Nagy Mohamed",
            "Somogyi Andrew A",
            "Skaar Todd C"
          ],
          "pmid": "33387367",
          "pmcid": null,
          "doi": "10.1002/cpt.2149",
          "month": 1,
          "year": 2021
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:2670",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CACNA1S",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "RYR1",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "desflurane",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for RYR1"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for CACNA1S"
            },
            {
              "annotation": "CACNA1S:Reference/Reference, RYR1:Reference/Reference",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for RYR1"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for CACNA1S"
            },
            {
              "annotation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:27340",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "desipramine",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Reduced metabolism of TCAs to less active compounds compared to normal metabolizers. Higher plasma concentrations of active drug will increase the probability of side effects.",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Consider a 25% reduction of recommended starting dose. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "term": "Recommendation"
            },
            {
              "annotation": "Optional",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPICÂ®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "MÃ¼ller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "MÃ¼ller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:3247",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "dexlansoprazole",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal PPI metabolism; may be at increased risk of therapeutic failure compared to CYP2C19 IMs and PMs",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "Initiate standard starting daily dose. Consider increasing dose by 50-100% for the treatment of H. pylori infection and erosive esophagitis. Daily dose may be given in divided doses. Monitor for efficacy.",
              "term": "Recommendation"
            },
            {
              "annotation": "Optional",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.",
          "authors": [
            "Lima John J",
            "Thomas Cameron D",
            "Barbarino Julia",
            "Desta Zeruesenay",
            "Van Driest Sara L",
            "El Rouby Nihal",
            "Johnson Julie A",
            "Cavallari Larisa H",
            "Shakhnovich Valentina",
            "Thacker David L",
            "Scott Stuart A",
            "Schwab Matthias",
            "Uppugunduri Chakradhara Rao S",
            "Formea Christine M",
            "Franciosi James P",
            "Sangkuhl Katrin",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Gammal Roseann S",
            "Furuta Takahisa"
          ],
          "pmid": "32770672",
          "pmcid": null,
          "doi": "10.1002/cpt.2015",
          "month": 8,
          "year": 2020
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:816346",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "doxepin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Reduced metabolism of TCAs to less active compounds compared to normal metabolizers; Higher plasma concentrations of active drug will increase the probability of side effects",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "Normal metabolism of tertiary amines",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38, CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Consider a 25% reduction of recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "term": "Recommendation"
            },
            {
              "annotation": "Optional",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPICÂ®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "MÃ¼ller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "MÃ¼ller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:3638",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2B6",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "efavirenz",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "child >40kg_adult",
              "term": "Population"
            },
            {
              "annotation": "Normal efavirenz metabolism",
              "term": "Implication for CYP2B6"
            },
            {
              "annotation": "CYP2B6:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2B6"
            },
            {
              "annotation": "Initiate efavirenz with standard dosing (600 mg/day)",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "The ENCORE study showed that in treatment-naÃ¯ve patients randomized to initiate efavirenz-based regimens (combined with tenofovir and emtricitabine), 400 mg/day was non-inferior to 600 mg/day regardless of CYP2B6 genotype (PMID 24522178).",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-containing Antiretroviral Therapy.",
          "authors": [
            "Desta Zeruesenay",
            "Gammal Roseann S",
            "Gong Li",
            "Whirl-Carrillo Michelle",
            "Gaur Aditya H",
            "Sukasem Chonlaphat",
            "Hockings Jennifer",
            "Myers Alan",
            "Swart Marelize",
            "Tyndale Rachel",
            "Masimirembwa Collen",
            "Iwuchukwu Otito F",
            "Chirwa Sanika",
            "Lennox Jeffrey",
            "Gaedigk Andrea",
            "Klein Teri",
            "Haas David W"
          ],
          "pmid": "31006110",
          "pmcid": null,
          "doi": null,
          "month": 4,
          "year": 2019
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:195085",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CACNA1S",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "RYR1",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "enflurane",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for RYR1"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for CACNA1S"
            },
            {
              "annotation": "CACNA1S:Reference/Reference, RYR1:Reference/Reference",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for RYR1"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for CACNA1S"
            },
            {
              "annotation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:3920",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "escitalopram",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal metabolism",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "Initiate therapy with recommended starting dose",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors",
          "authors": [
            "Hicks J Kevin",
            "Bishop Jeffrey R",
            "Sangkuhl Katrin",
            "MÃ¼ller Daniel J",
            "Ji Yuan",
            "Leckband Susan G",
            "Leeder J Steven",
            "Graham Rebecca L",
            "Chiulli Dana L",
            "LLerena AdriÃ¡n",
            "Skaar Todd C",
            "Scott Stuart A",
            "Stingl Julia C",
            "Klein Teri E",
            "Caudle Kelly E",
            "Gaedigk Andrea"
          ],
          "pmid": "25974703",
          "pmcid": "PMC4512908",
          "doi": "10.1002/cpt.147",
          "month": 5,
          "year": 2015
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:321988",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "DPYD",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "fluorouracil",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal DPD activity and \"normal\" risk for fluoropyrimidine toxicity",
              "term": "Implication for DPYD"
            },
            {
              "annotation": "DPYD:Reference/Reference",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for DPYD"
            },
            {
              "annotation": "2.0",
              "term": "Activity Score for DPYD"
            },
            {
              "annotation": "Based on genotype, there is no indication to change dose or therapy. Use label-recommended dosage and administration.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing",
          "authors": [
            "Caudle Kelly E",
            "Thorn Caroline F",
            "Klein Teri E",
            "Swen Jesse J",
            "McLeod Howard L",
            "Diasio Robert B",
            "Schwab Matthias"
          ],
          "pmid": "23988873",
          "pmcid": "PMC3831181",
          "doi": "10.1038/clpt.2013.172",
          "month": 8,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update",
          "authors": [
            "Amstutz Ursula",
            "Henricks Linda M",
            "Offer Steven M",
            "Barbarino Julia",
            "Schellens Jan H M",
            "Swen Jesse J",
            "Klein Teri E",
            "McLeod Howard L",
            "Caudle Kelly E",
            "Diasio Robert B",
            "Schwab Matthias"
          ],
          "pmid": "29152729",
          "pmcid": "PMC5760397",
          "doi": "10.1002/cpt.911",
          "month": 11,
          "year": 2017
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:4492",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C9",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "flurbiprofen",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal metabolism",
              "term": "Implication for CYP2C9"
            },
            {
              "annotation": "CYP2C9:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C9"
            },
            {
              "annotation": "2.0",
              "term": "Activity Score for CYP2C9"
            },
            {
              "annotation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "AgÃºndez JosÃ© A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:4502",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C9",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "SLCO1B1",
          "diplotypes": "*1/*1",
          "showHighlights": true,
          "highlightedVariants": [
            "rs4149056T/rs4149056T"
          ],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "fluvastatin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal exposure.",
              "term": "Implication for CYP2C9"
            },
            {
              "annotation": "Typical myopathy risk and statin exposure.",
              "term": "Implication for SLCO1B1"
            },
            {
              "annotation": "CYP2C9:*1/*1, SLCO1B1:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C9"
            },
            {
              "annotation": "Normal Function",
              "term": "Phenotype for SLCO1B1"
            },
            {
              "annotation": "2.0",
              "term": "Activity Score for CYP2C9"
            },
            {
              "annotation": "Prescribe desired starting dose and adjust doses of fluvastatin based on disease-specific guidelines.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:41127",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "fluvoxamine",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Reduced metabolism when compared to normal metabolizers. Higher plasma concentrations may increase the probability of side effects.",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Initiate therapy with recommended starting dose.",
              "term": "Recommendation"
            },
            {
              "annotation": "Moderate",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors",
          "authors": [
            "Hicks J Kevin",
            "Bishop Jeffrey R",
            "Sangkuhl Katrin",
            "MÃ¼ller Daniel J",
            "Ji Yuan",
            "Leckband Susan G",
            "Leeder J Steven",
            "Graham Rebecca L",
            "Chiulli Dana L",
            "LLerena AdriÃ¡n",
            "Skaar Todd C",
            "Scott Stuart A",
            "Stingl Julia C",
            "Klein Teri E",
            "Caudle Kelly E",
            "Gaedigk Andrea"
          ],
          "pmid": "25974703",
          "pmcid": "PMC4512908",
          "doi": "10.1002/cpt.147",
          "month": 5,
          "year": 2015
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:42355",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "MT-RNR1",
          "diplotypes": "1555A>G",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "increased risk of aminoglycoside-induced hearing loss",
          "outsideCall": true
        }
      ],
      "drugs": "gentamicin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic.",
              "term": "Implication for MT-RNR1"
            },
            {
              "annotation": "MT-RNR1:1555A>G",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "increased risk of aminoglycoside-induced hearing loss",
              "term": "Phenotype for MT-RNR1"
            },
            {
              "annotation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring).",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "messages": [],
      "matched": true,
      "id": "ATC:D06AX07",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CACNA1S",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "RYR1",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "halothane",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for RYR1"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for CACNA1S"
            },
            {
              "annotation": "CACNA1S:Reference/Reference, RYR1:Reference/Reference",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for RYR1"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for CACNA1S"
            },
            {
              "annotation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:5095",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "hydrocodone",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Minimal evidence for pharmacokinetic or clinical effect.",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "1",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Use hydrocodone label recommended age- or weight-specific dosing. If no response and opioid use is warranted, consider non-codeine or non-tramadol opioid.",
              "term": "Recommendation"
            },
            {
              "annotation": "Optional",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype",
          "authors": [
            "Crews K R",
            "Gaedigk A",
            "Dunnenberger H M",
            "Klein T E",
            "Shen D D",
            "Callaghan J T",
            "Kharasch E D",
            "Skaar T C"
          ],
          "pmid": "22205192",
          "pmcid": "PMC3289963",
          "doi": "10.1038/clpt.2011.287",
          "month": 12,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy: 2014 Update",
          "authors": [
            "Crews Kristine R",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Leeder J Steve",
            "Klein Teri E",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Shen Danny D",
            "Callaghan John T",
            "Sadhasivam Senthilkumar",
            "Prows Cynthia A",
            "Kharasch Evan D",
            "Skaar Todd C"
          ],
          "pmid": "24458010",
          "pmcid": "PMC3975212",
          "doi": "10.1038/clpt.2013.254",
          "month": 1,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy.",
          "authors": [
            "Crews Kristine R",
            "Monte Andrew A",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Kharasch Evan D",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Leeder J Steven",
            "Callaghan John T",
            "Samer Caroline Flora",
            "Klein Teri E",
            "Haidar Cyrine E",
            "Van Driest Sara L",
            "Ruano Gualberto",
            "Sangkuhl Katrin",
            "Cavallari Larisa H",
            "MÃ¼ller Daniel J",
            "Prows Cynthia A",
            "Nagy Mohamed",
            "Somogyi Andrew A",
            "Skaar Todd C"
          ],
          "pmid": "33387367",
          "pmcid": null,
          "doi": "10.1002/cpt.2149",
          "month": 1,
          "year": 2021
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:5489",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C9",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "ibuprofen",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal metabolism",
              "term": "Implication for CYP2C9"
            },
            {
              "annotation": "CYP2C9:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C9"
            },
            {
              "annotation": "2.0",
              "term": "Activity Score for CYP2C9"
            },
            {
              "annotation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "AgÃºndez JosÃ© A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:5640",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "imipramine",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Reduced metabolism of TCAs to less active compounds compared to normal metabolizers; Higher plasma concentrations of active drug will increase the probability of side effects",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "Normal metabolism of tertiary amines",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38, CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Consider a 25% reduction of recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "term": "Recommendation"
            },
            {
              "annotation": "Optional",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPICÂ®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "MÃ¼ller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "MÃ¼ller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:5691",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CACNA1S",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "RYR1",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "isoflurane",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for RYR1"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for CACNA1S"
            },
            {
              "annotation": "CACNA1S:Reference/Reference, RYR1:Reference/Reference",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for RYR1"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for CACNA1S"
            },
            {
              "annotation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:6026",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CFTR",
          "diplotypes": "No CPIC variants found",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two ivacaftor non-responsive alleles",
          "outsideCall": false
        }
      ],
      "drugs": "ivacaftor",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "An individual diagnosed with cystic fibrosis (CF) and negative for a CFTR variant listed in the FDA-approved drug label as being responsive to ivacaftor.",
              "term": "Implication for CFTR"
            },
            {
              "annotation": "CFTR:No CPIC variants found",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "ivacaftor non-responsive in CF patients",
              "term": "Phenotype for CFTR"
            },
            {
              "annotation": "Ivacaftor is not recommended",
              "term": "Recommendation"
            },
            {
              "annotation": "Moderate",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype",
          "authors": [
            "Clancy John P",
            "Johnson Samuel G",
            "Yee Sook Wah",
            "McDonagh Ellen M",
            "Caudle Kelly E",
            "Klein Teri E",
            "Cannavo Matthew",
            "Giacomini Kathleen M"
          ],
          "pmid": "24598717",
          "pmcid": "PMC4026598",
          "doi": "10.1038/clpt.2014.54",
          "month": 3,
          "year": 2014
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:1243041",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "MT-RNR1",
          "diplotypes": "1555A>G",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "increased risk of aminoglycoside-induced hearing loss",
          "outsideCall": true
        }
      ],
      "drugs": "kanamycin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic.",
              "term": "Implication for MT-RNR1"
            },
            {
              "annotation": "MT-RNR1:1555A>G",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "increased risk of aminoglycoside-induced hearing loss",
              "term": "Phenotype for MT-RNR1"
            },
            {
              "annotation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring).",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:6099",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "lansoprazole",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal PPI metabolism; may be at increased risk of therapeutic failure compared to CYP2C19 IMs and PMs",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "Initiate standard starting daily dose. Consider increasing dose by 50-100% for the treatment of H. pylori infection and erosive esophagitis. Daily dose may be given in divided doses. Monitor for efficacy.",
              "term": "Recommendation"
            },
            {
              "annotation": "Moderate",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.",
          "authors": [
            "Lima John J",
            "Thomas Cameron D",
            "Barbarino Julia",
            "Desta Zeruesenay",
            "Van Driest Sara L",
            "El Rouby Nihal",
            "Johnson Julie A",
            "Cavallari Larisa H",
            "Shakhnovich Valentina",
            "Thacker David L",
            "Scott Stuart A",
            "Schwab Matthias",
            "Uppugunduri Chakradhara Rao S",
            "Formea Christine M",
            "Franciosi James P",
            "Sangkuhl Katrin",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Gammal Roseann S",
            "Furuta Takahisa"
          ],
          "pmid": "32770672",
          "pmcid": null,
          "doi": "10.1002/cpt.2015",
          "month": 8,
          "year": 2020
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:17128",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C9",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "lornoxicam",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal metabolism",
              "term": "Implication for CYP2C9"
            },
            {
              "annotation": "CYP2C9:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C9"
            },
            {
              "annotation": "2.0",
              "term": "Activity Score for CYP2C9"
            },
            {
              "annotation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "AgÃºndez JosÃ© A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:20890",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "SLCO1B1",
          "diplotypes": "*1/*1",
          "showHighlights": true,
          "highlightedVariants": [
            "rs4149056T/rs4149056T"
          ],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "lovastatin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "population general",
              "term": "Population"
            },
            {
              "annotation": "Typical myopathy risk and statin exposure",
              "term": "Implication for SLCO1B1"
            },
            {
              "annotation": "SLCO1B1:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Function",
              "term": "Phenotype for SLCO1B1"
            },
            {
              "annotation": "Prescribe desired starting dose and adjust doses based on disease-specific guidelines.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:6472",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C9",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "meloxicam",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal metabolism",
              "term": "Implication for CYP2C9"
            },
            {
              "annotation": "CYP2C9:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C9"
            },
            {
              "annotation": "2.0",
              "term": "Activity Score for CYP2C9"
            },
            {
              "annotation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "AgÃºndez JosÃ© A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:41493",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "NUDT15",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "TPMT",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "mercaptopurine",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Lower concentrations of TGN metabolites, higher MeTIMP, this is the â€˜normalâ€™ pattern. Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression.",
              "term": "Implication for TPMT"
            },
            {
              "annotation": "Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression",
              "term": "Implication for NUDT15"
            },
            {
              "annotation": "NUDT15:*1/*1, TPMT:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for TPMT"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for NUDT15"
            },
            {
              "annotation": "Start with normal starting dose (e.g., 75 mg/m2/day or 1.5 mg/kg/day) and adjust doses of mercaptopurine (and of any other myelosuppressive therapy) without any special emphasis on mercaptopurine compared to other agents. Allow at least 2 weeks to reach steady-state after each dose adjustment (PMID 20354201, 16401827, 11302950).",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Normal starting doses vary by race/ethnicity and treatment regimens. If standard dose is below normal recommended dose, dose reduction might not be recommended for intermediate metabolizers.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Klein T E"
          ],
          "pmid": "21270794",
          "pmcid": "PMC3098761",
          "doi": "10.1038/clpt.2010.320",
          "month": 3,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Hicks J K",
            "Schwab M",
            "Klein T E"
          ],
          "pmid": "23422873",
          "pmcid": "PMC3604643",
          "doi": "10.1038/clpt.2013.4",
          "month": 1,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update.",
          "authors": [
            "Relling Mary V",
            "Schwab Matthias",
            "Whirl-Carrillo Michelle",
            "Suarez-Kurtz Guilherme",
            "Pui Ching-Hon",
            "Stein Charles M",
            "Moyer Ann M",
            "Evans William E",
            "Klein Teri E",
            "Antillon-Klussmann Federico Guillermo",
            "Caudle Kelly E",
            "Kato Motohiro",
            "Yeoh Allen E J",
            "Schmiegelow Kjeld",
            "Yang Jun J"
          ],
          "pmid": "30447069",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:103",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CACNA1S",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "RYR1",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "methoxyflurane",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for RYR1"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for CACNA1S"
            },
            {
              "annotation": "CACNA1S:Reference/Reference, RYR1:Reference/Reference",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for RYR1"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for CACNA1S"
            },
            {
              "annotation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:6857",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "nortriptyline",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Reduced metabolism of tricyclic antidepressants to less active compounds compared to normal metabolizers. Higher plasma concentrations of active drug will increase the probability of side effects.",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Consider a 25% reduction of recommended starting dose. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "term": "Recommendation"
            },
            {
              "annotation": "Optional",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of tricyclic antidepressants for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPICÂ®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "MÃ¼ller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "MÃ¼ller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:7531",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "omeprazole",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal PPI metabolism; may be at increased risk of therapeutic failure compared to CYP2C19 IMs and PMs",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "Initiate standard starting daily dose. Consider increasing dose by 50-100% for the treatment of H. pylori infection and erosive esophagitis. Daily dose may be given in divided doses. Monitor for efficacy.",
              "term": "Recommendation"
            },
            {
              "annotation": "Moderate",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.",
          "authors": [
            "Lima John J",
            "Thomas Cameron D",
            "Barbarino Julia",
            "Desta Zeruesenay",
            "Van Driest Sara L",
            "El Rouby Nihal",
            "Johnson Julie A",
            "Cavallari Larisa H",
            "Shakhnovich Valentina",
            "Thacker David L",
            "Scott Stuart A",
            "Schwab Matthias",
            "Uppugunduri Chakradhara Rao S",
            "Formea Christine M",
            "Franciosi James P",
            "Sangkuhl Katrin",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Gammal Roseann S",
            "Furuta Takahisa"
          ],
          "pmid": "32770672",
          "pmcid": null,
          "doi": "10.1002/cpt.2015",
          "month": 8,
          "year": 2020
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:7646",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "ondansetron",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Very limited data available for CYP2D6 intermediate metabolizers",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Insufficient evidence demonstrating clinical impact based on CYP2D6 genotype. Initiate therapy with recommended starting dose.",
              "term": "Recommendation"
            },
            {
              "annotation": "No Recommendation",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Drug-drug interactions and other patient characteristics (e.g., age, renal function, and liver function) should be considered when selecting alternative therapy.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron",
          "authors": [
            "Bell Gillian C",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Gordon Ronald J",
            "Hikino Keiko",
            "Prows Cynthia A",
            "Gaedigk Andrea",
            "Agundez Jose A G",
            "Sadhasivam Senthilkumar",
            "Klein Teri E",
            "Schwab Matthias"
          ],
          "pmid": "28002639",
          "pmcid": "PMC5479760",
          "doi": "10.1002/cpt.598",
          "month": 12,
          "year": 2016
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:26225",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "pantoprazole",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal PPI metabolism; may be at increased risk of therapeutic failure compared to CYP2C19 IMs and PMs",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "Initiate standard starting daily dose. Consider increasing dose by 50-100% for the treatment of H. pylori infection and erosive esophagitis. Daily dose may be given in divided doses. Monitor for efficacy.",
              "term": "Recommendation"
            },
            {
              "annotation": "Moderate",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.",
          "authors": [
            "Lima John J",
            "Thomas Cameron D",
            "Barbarino Julia",
            "Desta Zeruesenay",
            "Van Driest Sara L",
            "El Rouby Nihal",
            "Johnson Julie A",
            "Cavallari Larisa H",
            "Shakhnovich Valentina",
            "Thacker David L",
            "Scott Stuart A",
            "Schwab Matthias",
            "Uppugunduri Chakradhara Rao S",
            "Formea Christine M",
            "Franciosi James P",
            "Sangkuhl Katrin",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Gammal Roseann S",
            "Furuta Takahisa"
          ],
          "pmid": "32770672",
          "pmcid": null,
          "doi": "10.1002/cpt.2015",
          "month": 8,
          "year": 2020
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:40790",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "MT-RNR1",
          "diplotypes": "1555A>G",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "increased risk of aminoglycoside-induced hearing loss",
          "outsideCall": true
        }
      ],
      "drugs": "paromomycin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic.",
              "term": "Implication for MT-RNR1"
            },
            {
              "annotation": "MT-RNR1:1555A>G",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "increased risk of aminoglycoside-induced hearing loss",
              "term": "Phenotype for MT-RNR1"
            },
            {
              "annotation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring).",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:7934",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "paroxetine",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Reduced metabolism when compared to normal metabolizers. Higher plasma concentrations may increase the probability of side effects.",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Initiate therapy with recommended starting dose",
              "term": "Recommendation"
            },
            {
              "annotation": "Moderate",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors",
          "authors": [
            "Hicks J Kevin",
            "Bishop Jeffrey R",
            "Sangkuhl Katrin",
            "MÃ¼ller Daniel J",
            "Ji Yuan",
            "Leckband Susan G",
            "Leeder J Steven",
            "Graham Rebecca L",
            "Chiulli Dana L",
            "LLerena AdriÃ¡n",
            "Skaar Todd C",
            "Scott Stuart A",
            "Stingl Julia C",
            "Klein Teri E",
            "Caudle Kelly E",
            "Gaedigk Andrea"
          ],
          "pmid": "25974703",
          "pmcid": "PMC4512908",
          "doi": "10.1002/cpt.147",
          "month": 5,
          "year": 2015
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:32937",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "IFNL3/4",
          "diplotypes": "rs12979860 reference (C)/rs12979860 reference (C)",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "N/A",
          "outsideCall": false
        }
      ],
      "drugs": "peginterferon alfa-2a",
      "groups": [],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-peg-interferon-alpha-based-regimens-and-ifnl3/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and peginterferon alpha based regimens",
          "authors": [
            "Muir Andrew J",
            "Gong Li",
            "Johnson Samuel G",
            "Michael Lee Ming Ta",
            "Williams Marc S",
            "Klein Teri E",
            "Caudle Kelly E",
            "Nelson David R"
          ],
          "pmid": "24096968",
          "pmcid": "PMC3904555",
          "doi": "10.1038/clpt.2013.203",
          "month": 10,
          "year": 2013
        }
      ],
      "messages": [],
      "matched": false,
      "id": "RxNorm:120608",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "IFNL3/4",
          "diplotypes": "rs12979860 reference (C)/rs12979860 reference (C)",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "N/A",
          "outsideCall": false
        }
      ],
      "drugs": "peginterferon alfa-2b",
      "groups": [],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-peg-interferon-alpha-based-regimens-and-ifnl3/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and peginterferon alpha based regimens",
          "authors": [
            "Muir Andrew J",
            "Gong Li",
            "Johnson Samuel G",
            "Michael Lee Ming Ta",
            "Williams Marc S",
            "Klein Teri E",
            "Caudle Kelly E",
            "Nelson David R"
          ],
          "pmid": "24096968",
          "pmcid": "PMC3904555",
          "doi": "10.1038/clpt.2013.203",
          "month": 10,
          "year": 2013
        }
      ],
      "messages": [],
      "matched": false,
      "id": "RxNorm:253453",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C9",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "piroxicam",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal metabolism",
              "term": "Implication for CYP2C9"
            },
            {
              "annotation": "CYP2C9:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C9"
            },
            {
              "annotation": "2.0",
              "term": "Activity Score for CYP2C9"
            },
            {
              "annotation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "AgÃºndez JosÃ© A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:8356",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "SLCO1B1",
          "diplotypes": "*1/*1",
          "showHighlights": true,
          "highlightedVariants": [
            "rs4149056T/rs4149056T"
          ],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "pitavastatin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "population general",
              "term": "Population"
            },
            {
              "annotation": "Typical myopathy risk and statin exposure",
              "term": "Implication for SLCO1B1"
            },
            {
              "annotation": "SLCO1B1:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Function",
              "term": "Phenotype for SLCO1B1"
            },
            {
              "annotation": "Prescribe desired starting dose and adjust doses based on disease-specific guidelines.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:861634",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "MT-RNR1",
          "diplotypes": "1555A>G",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "increased risk of aminoglycoside-induced hearing loss",
          "outsideCall": true
        }
      ],
      "drugs": "plazomicin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic.",
              "term": "Implication for MT-RNR1"
            },
            {
              "annotation": "MT-RNR1:1555A>G",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "increased risk of aminoglycoside-induced hearing loss",
              "term": "Phenotype for MT-RNR1"
            },
            {
              "annotation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring).",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:2049549",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "SLCO1B1",
          "diplotypes": "*1/*1",
          "showHighlights": true,
          "highlightedVariants": [
            "rs4149056T/rs4149056T"
          ],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "pravastatin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "population general",
              "term": "Population"
            },
            {
              "annotation": "Typical myopathy risk and statin exposure",
              "term": "Implication for SLCO1B1"
            },
            {
              "annotation": "SLCO1B1:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Function",
              "term": "Phenotype for SLCO1B1"
            },
            {
              "annotation": "Prescribe desired starting dose and adjust doses based on disease-specific guidelines.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:42463",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "G6PD",
          "diplotypes": "B (wildtype)/B (wildtype)",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": true
        }
      ],
      "drugs": "rasburicase",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Low or reduced risk of hemolytic anemia",
              "term": "Implication for G6PD"
            },
            {
              "annotation": "G6PD:B (wildtype)/B (wildtype)",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal",
              "term": "Phenotype for G6PD"
            },
            {
              "annotation": "No reason to withhold rasburicase based on G6PD status.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "A negative or inconclusive genetic test cannot be assumed to indicate normal G6PD phenotype; an enzyme actiity test is needed to assign G6PD phenotype in such cases.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-rasburicase-and-g6pd/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the context of G6PD Deficiency Genotype",
          "authors": [
            "Relling Mary V",
            "McDonagh Ellen M",
            "Chang Tamara",
            "Caudle Kelly E",
            "McLeod Howard L",
            "Haidar Cyrine E",
            "Klein Teri",
            "Luzzatto Lucio"
          ],
          "pmid": "24787449",
          "pmcid": "PMC4111801",
          "doi": "10.1038/clpt.2014.97",
          "month": 5,
          "year": 2014
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:283821",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "ABCG2",
          "diplotypes": "rs2231142 reference (G)/rs2231142 reference (G)",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "SLCO1B1",
          "diplotypes": "*1/*1",
          "showHighlights": true,
          "highlightedVariants": [
            "rs4149056T/rs4149056T"
          ],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "rosuvastatin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Typical myopathy risk and rosuvastatin exposure",
              "term": "Implication for ABCG2"
            },
            {
              "annotation": "Typical myopathy risk and statin exposure",
              "term": "Implication for SLCO1B1"
            },
            {
              "annotation": "ABCG2:rs2231142 reference (G)/rs2231142 reference (G), SLCO1B1:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Function",
              "term": "Phenotype for ABCG2"
            },
            {
              "annotation": "Normal Function",
              "term": "Phenotype for SLCO1B1"
            },
            {
              "annotation": "Prescribe desired starting dose and adjust doses of rosuvastatin based on disease-specific and specific population guidelines.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and Asian ancestry should be evaluated prior to initiating rosuvastatin.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:301542",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "sertraline",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal metabolism",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "Initiate therapy with recommended starting dose",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors",
          "authors": [
            "Hicks J Kevin",
            "Bishop Jeffrey R",
            "Sangkuhl Katrin",
            "MÃ¼ller Daniel J",
            "Ji Yuan",
            "Leckband Susan G",
            "Leeder J Steven",
            "Graham Rebecca L",
            "Chiulli Dana L",
            "LLerena AdriÃ¡n",
            "Skaar Todd C",
            "Scott Stuart A",
            "Stingl Julia C",
            "Klein Teri E",
            "Caudle Kelly E",
            "Gaedigk Andrea"
          ],
          "pmid": "25974703",
          "pmcid": "PMC4512908",
          "doi": "10.1002/cpt.147",
          "month": 5,
          "year": 2015
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:36437",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CACNA1S",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "RYR1",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "sevoflurane",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for RYR1"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for CACNA1S"
            },
            {
              "annotation": "CACNA1S:Reference/Reference, RYR1:Reference/Reference",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for RYR1"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for CACNA1S"
            },
            {
              "annotation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:36453",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "SLCO1B1",
          "diplotypes": "*1/*1",
          "showHighlights": true,
          "highlightedVariants": [
            "rs4149056T/rs4149056T"
          ],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "simvastatin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Typical myopathy risk and statin exposure",
              "term": "Implication for SLCO1B1"
            },
            {
              "annotation": "SLCO1B1:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Function",
              "term": "Phenotype for SLCO1B1"
            },
            {
              "annotation": "Prescribe desired starting dose and adjust doses based on disease-specific guidelines.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "messages": [
        "The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.",
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:36567",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "MT-RNR1",
          "diplotypes": "1555A>G",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "increased risk of aminoglycoside-induced hearing loss",
          "outsideCall": true
        }
      ],
      "drugs": "streptomycin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic.",
              "term": "Implication for MT-RNR1"
            },
            {
              "annotation": "MT-RNR1:1555A>G",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "increased risk of aminoglycoside-induced hearing loss",
              "term": "Phenotype for MT-RNR1"
            },
            {
              "annotation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring).",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:10109",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CACNA1S",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "RYR1",
          "diplotypes": "Reference/Reference",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "succinylcholine",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for RYR1"
            },
            {
              "annotation": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
              "term": "Implication for CACNA1S"
            },
            {
              "annotation": "CACNA1S:Reference/Reference, RYR1:Reference/Reference",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for RYR1"
            },
            {
              "annotation": "Uncertain Susceptibility",
              "term": "Phenotype for CACNA1S"
            },
            {
              "annotation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:10154",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP3A5",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "tacrolimus",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Lower dose-adjusted trough concentrations of tacrolimus and decreased chance of achieving target tacrolimus concentrations.",
              "term": "Implication for CYP3A5"
            },
            {
              "annotation": "CYP3A5:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP3A5"
            },
            {
              "annotation": "Increase starting dose 1.5 to 2 times recommended starting dose. Total starting dose should not exceed 0.3 mg/kg/day. Use therapeutic drug monitoring to guide dose adjustments.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "This recommendation includes the use of tacrolimus in kidney, heart, lung and hematopoietic stem cell transplant patients, and liver transplant patients where the donor and recipient genotypes are identical. Further dose adjustments or selection of alternative therapy may be necessary due to other clinical factors (e.g., medication interactions, or hepatic function). Typically with other CYP enzymes, a normal metabolizer would be classified as having normal metabolism, and therefore, the drug dose would not change based on the patientâ€™s genotype. However, in the case of CYP3A5 and tacrolimus, a CYP3A5 expresser (i.e., CYP3A5 normal metabolizer or intermediate metabolizer) would require a higher recommended starting dose, and the CYP3A5 non-expresser (i.e., poor metabolizer) would require the standard recommended starting dose.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-tacrolimus-and-cyp3a5/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing",
          "authors": [
            "Birdwell Kelly A",
            "Decker Brian",
            "Barbarino Julia M",
            "Peterson Josh F",
            "Stein C Michael",
            "Sadee Wolfgang",
            "Wang Danxin",
            "Vinks Alexander A",
            "He Yijing",
            "Swen Jesse J",
            "Leeder J Steven",
            "van Schaik R H N",
            "Thummel Kenneth E",
            "Klein Teri E",
            "Caudle Kelly E",
            "MacPhee Iain A M"
          ],
          "pmid": "25801146",
          "pmcid": "PMC4481158",
          "doi": "10.1002/cpt.113",
          "month": 3,
          "year": 2015
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:42316",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "tamoxifen",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Lower endoxifen concentrations compared to normal metabolizers; higher risk of breast cancer recurrence, event-free and recurrence-free survival compared to normal metabolizers.",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Consider hormonal therapy such as an aromatase inhibitor for postmenopausal women or aromatase inhibitor along with ovarian function suppression in premenopausal women, given that these approaches are superior to tamoxifen regardless of CYP2D6 genotype (PMID 26211827). If aromatase inhibitor use is contraindicated, consideration should be given to use a higher but FDA approved tamoxifen dose (40 mg/day)(PMID 27226358). Avoid CYP2D6 strong to weak inhibitors.",
              "term": "Recommendation"
            },
            {
              "annotation": "Optional",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.",
          "authors": [
            "Goetz Matthew P",
            "Sangkuhl Katrin",
            "Guchelaar Henk-Jan",
            "Schwab Matthias",
            "Province Michael",
            "Whirl-Carrillo Michelle",
            "Symmans W Fraser",
            "McLeod Howard L",
            "Ratain Mark J",
            "Zembutsu Hitoshi",
            "Gaedigk Andrea",
            "van Schaik Ron H",
            "Ingle James N",
            "Caudle Kelly E",
            "Klein Teri E"
          ],
          "pmid": "29385237",
          "pmcid": "PMC5931215",
          "doi": "10.1002/cpt.1007",
          "month": 5,
          "year": 2018
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:10324",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C9",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "tenoxicam",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Normal metabolism",
              "term": "Implication for CYP2C9"
            },
            {
              "annotation": "CYP2C9:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C9"
            },
            {
              "annotation": "2.0",
              "term": "Activity Score for CYP2C9"
            },
            {
              "annotation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "AgÃºndez JosÃ© A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:37790",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "NUDT15",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "TPMT",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "thioguanine",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Lower concentrations of TGN metabolites, but note that TGN after thioguanine are 5-10X higher than TGN after mercaptopurine or azathioprine. Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression.",
              "term": "Implication for TPMT"
            },
            {
              "annotation": "Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression",
              "term": "Implication for NUDT15"
            },
            {
              "annotation": "NUDT15:*1/*1, TPMT:*1/*1",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for TPMT"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for NUDT15"
            },
            {
              "annotation": "Start with normal starting dose (e.g., 40-60 mg/m2/day) and adjust doses of thioguanine and of other myelosuppressive therapy without any special emphasis on thioguanine. Allow 2 weeks to reach steady-state after each dose adjustment (PMID 20354201, 11037857).",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Normal starting doses vary by race/ethnicity and treatment regimens. If standard dose is below normal recommended dose, dose reduction might not be recommended for intermediate metabolizers.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Klein T E"
          ],
          "pmid": "21270794",
          "pmcid": "PMC3098761",
          "doi": "10.1038/clpt.2010.320",
          "month": 3,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Hicks J K",
            "Schwab M",
            "Klein T E"
          ],
          "pmid": "23422873",
          "pmcid": "PMC3604643",
          "doi": "10.1038/clpt.2013.4",
          "month": 1,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update.",
          "authors": [
            "Relling Mary V",
            "Schwab Matthias",
            "Whirl-Carrillo Michelle",
            "Suarez-Kurtz Guilherme",
            "Pui Ching-Hon",
            "Stein Charles M",
            "Moyer Ann M",
            "Evans William E",
            "Klein Teri E",
            "Antillon-Klussmann Federico Guillermo",
            "Caudle Kelly E",
            "Kato Motohiro",
            "Yeoh Allen E J",
            "Schmiegelow Kjeld",
            "Yang Jun J"
          ],
          "pmid": "30447069",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:10485",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "MT-RNR1",
          "diplotypes": "1555A>G",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "increased risk of aminoglycoside-induced hearing loss",
          "outsideCall": true
        }
      ],
      "drugs": "tobramycin",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic.",
              "term": "Implication for MT-RNR1"
            },
            {
              "annotation": "MT-RNR1:1555A>G",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "increased risk of aminoglycoside-induced hearing loss",
              "term": "Phenotype for MT-RNR1"
            },
            {
              "annotation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring).",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:10627",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "tramadol",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Reduced O-desmethyltramadol (active metabolite) formation",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "1",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Use tramadol label recommended age- or weight-specific dosing. If no response and opioid use is warranted, consider non-codeine opioid.",
              "term": "Recommendation"
            },
            {
              "annotation": "Optional",
              "term": "Classification of Recommendation"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype",
          "authors": [
            "Crews K R",
            "Gaedigk A",
            "Dunnenberger H M",
            "Klein T E",
            "Shen D D",
            "Callaghan J T",
            "Kharasch E D",
            "Skaar T C"
          ],
          "pmid": "22205192",
          "pmcid": "PMC3289963",
          "doi": "10.1038/clpt.2011.287",
          "month": 12,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy: 2014 Update",
          "authors": [
            "Crews Kristine R",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Leeder J Steve",
            "Klein Teri E",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Shen Danny D",
            "Callaghan John T",
            "Sadhasivam Senthilkumar",
            "Prows Cynthia A",
            "Kharasch Evan D",
            "Skaar Todd C"
          ],
          "pmid": "24458010",
          "pmcid": "PMC3975212",
          "doi": "10.1038/clpt.2013.254",
          "month": 1,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy.",
          "authors": [
            "Crews Kristine R",
            "Monte Andrew A",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Kharasch Evan D",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Leeder J Steven",
            "Callaghan John T",
            "Samer Caroline Flora",
            "Klein Teri E",
            "Haidar Cyrine E",
            "Van Driest Sara L",
            "Ruano Gualberto",
            "Sangkuhl Katrin",
            "Cavallari Larisa H",
            "MÃ¼ller Daniel J",
            "Prows Cynthia A",
            "Nagy Mohamed",
            "Somogyi Andrew A",
            "Skaar Todd C"
          ],
          "pmid": "33387367",
          "pmcid": null,
          "doi": "10.1002/cpt.2149",
          "month": 1,
          "year": 2021
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:10689",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "trimipramine",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Reduced metabolism of TCAs to less active compounds compared to normal metabolizers; Higher plasma concentrations of active drug will increase the probability of side effects",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "Normal metabolism of tertiary amines",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38, CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Consider a 25% reduction of recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "term": "Recommendation"
            },
            {
              "annotation": "Optional",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPICÂ®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "MÃ¼ller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "MÃ¼ller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:10834",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2D6",
          "diplotypes": "*1/*3",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "One no function allele and one normal function allele",
          "outsideCall": true
        }
      ],
      "drugs": "tropisetron",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "general",
              "term": "Population"
            },
            {
              "annotation": "Very limited data available for CYP2D6 intermediate metabolizers",
              "term": "Implication for CYP2D6"
            },
            {
              "annotation": "CYP2D6:*1/*3",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Intermediate Metabolizer",
              "term": "Phenotype for CYP2D6"
            },
            {
              "annotation": "1.0",
              "term": "Activity Score for CYP2D6"
            },
            {
              "annotation": "Insufficient evidence demonstrating clinical impact based on CYP2D6 genotype. Initiate therapy with recommended starting dose.",
              "term": "Recommendation"
            },
            {
              "annotation": "No Recommendation",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Drug-drug interactions and other patient characteristics (e.g., age, renal function, and liver function) should be considered when selecting alternative therapy.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron",
          "authors": [
            "Bell Gillian C",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Gordon Ronald J",
            "Hikino Keiko",
            "Prows Cynthia A",
            "Gaedigk Andrea",
            "Agundez Jose A G",
            "Sadhasivam Senthilkumar",
            "Klein Teri E",
            "Schwab Matthias"
          ],
          "pmid": "28002639",
          "pmcid": "PMC5479760",
          "doi": "10.1002/cpt.598",
          "month": 12,
          "year": 2016
        }
      ],
      "messages": [
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:27392",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C19",
          "diplotypes": "*38/*38",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        }
      ],
      "drugs": "voriconazole",
      "groups": [
        {
          "annotations": [
            {
              "annotation": "adults",
              "term": "Population"
            },
            {
              "annotation": "Normal voriconazole metabolism",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "Initiate therapy with recommended standard of care dosing",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Further dose adjustments or selection of alternative therapy may be necessary due to other clinical factors, such as drug interactions, hepatic function, renal function, species, site of infection, therapeutic drug monitoring, and comorbidities.",
              "term": "Comments"
            }
          ]
        },
        {
          "annotations": [
            {
              "annotation": "pediatrics",
              "term": "Population"
            },
            {
              "annotation": "Normal voriconazole metabolism",
              "term": "Implication for CYP2C19"
            },
            {
              "annotation": "CYP2C19:*38/*38",
              "term": "Matched Diplotypes"
            },
            {
              "annotation": "Normal Metabolizer",
              "term": "Phenotype for CYP2C19"
            },
            {
              "annotation": "Initiate therapy with recommended standard of care dosing",
              "term": "Recommendation"
            },
            {
              "annotation": "Strong",
              "term": "Classification of Recommendation"
            },
            {
              "annotation": "Further dose adjustments or selection of alternative therapy may be necessary due to other clinical factors, such as drug interactions, hepatic function, renal function, species, site of infection, therapeutic drug monitoring, and comorbidities.",
              "term": "Comments"
            }
          ]
        }
      ],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/",
      "mutliMatch": true,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPICÂ®) Guideline for CYP2C19 and Voriconazole Therapy",
          "authors": [
            "Moriyama Brad",
            "Obeng Aniwaa Owusu",
            "Barbarino Julia",
            "Penzak Scott R",
            "Henning Stacey A",
            "Scott Stuart A",
            "AgÃºndez JosÃ© A G",
            "Wingard John R",
            "McLeod Howard L",
            "Klein Teri E",
            "Cross Shane",
            "Caudle Kelly E",
            "Walsh Thomas J"
          ],
          "pmid": "27981572",
          "pmcid": "PMC5474211",
          "doi": "10.1002/cpt.583",
          "month": 12,
          "year": 2016
        }
      ],
      "messages": [],
      "matched": true,
      "id": "RxNorm:121243",
      "lastModified": "not available",
      "footnotes": []
    },
    {
      "image": {
        "url": "https://files.cpicpgx.org/images/warfarin/warfarin_recommendation_diagram.png",
        "altText": "Figure 2 from the CPIC guideline for warfarin"
      },
      "uncalledGenes": "",
      "geneCalls": [
        {
          "gene": "CYP2C9",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "Two normal function alleles",
          "outsideCall": false
        },
        {
          "gene": "CYP4F2",
          "diplotypes": "*1/*1",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "N/A",
          "outsideCall": false
        },
        {
          "gene": "VKORC1",
          "diplotypes": "rs9923231 reference (C)/rs9923231 reference (C)",
          "showHighlights": false,
          "highlightedVariants": [],
          "functions": "N/A",
          "outsideCall": false
        },
        {
          "gene": "rs12777823",
          "diplotypes": "G|G",
          "outsideCall": false
        }
      ],
      "drugs": "warfarin",
      "groups": [],
      "reportable": true,
      "url": "https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/",
      "mutliMatch": false,
      "citations": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing",
          "authors": [
            "Johnson J A",
            "Gong L",
            "Whirl-Carrillo M",
            "Gage B F",
            "Scott S A",
            "Stein C M",
            "Anderson J L",
            "Kimmel S E",
            "Lee M T M",
            "Pirmohamed M",
            "Wadelius M",
            "Klein T E",
            "Altman R B"
          ],
          "pmid": "21900891",
          "pmcid": "PMC3187550",
          "doi": "10.1038/clpt.2011.185",
          "month": 9,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical pharmacogenetics implementation consortium (cpic) guideline for pharmacogenetics-guided warfarin dosing: 2017 update",
          "authors": [
            "Johnson Julie A",
            "Caudle Kelly E",
            "Gong Li",
            "Whirl-Carrillo Michelle",
            "Stein C Michael",
            "Scott Stuart A",
            "Lee Ming Ta Michael",
            "Gage Brian F",
            "Kimmel Stephen E",
            "Perera Minoli A",
            "Anderson Jeffrey L",
            "Pirmohamed Munir",
            "Klein Teri E",
            "Limdi Nita A",
            "Cavallari Larisa H",
            "Wadelius Mia"
          ],
          "pmid": "28198005",
          "pmcid": "PMC5546947",
          "doi": "10.1002/cpt.668",
          "month": 2,
          "year": 2017
        }
      ],
      "messages": [
        "Please follow the flow chart in figure 2 of the <a href=\"https://www.pharmgkb.org/guideline/PA166104949\">CPIC warfarin guideline</a> to determine the appropriate dosing recommendation.",
        "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
      ],
      "matched": true,
      "id": "RxNorm:11289",
      "lastModified": "not available",
      "footnotes": [
        "The CPIC warfarin guideline only considers a single SNV in VKORC1 (rs9923231), which is found in the highest frequency in Caucasians and extremely low frequency in those of African descent. While other functional variants in VKORC1 have been observed in much higher frequencies in some populations, there are currently no CPIC recommendations for how to use these other variants in warfarin dosing. An alternate name for rs9923231 is -1639G>A (note that VKORC1 is on the negative chromosomal strand, so displayed alleles are complemented). "
      ]
    }
  ],
  "title": "pharmcat_positions"
}